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Abstract 37 
Contaminants of emerging concern (CEC) discharged in effluents of wastewater treatment plants 38 
(WWTPs), not specifically designed for their removal, pose serious hazards to human health and 39 
ecosystems. Their impact is of particular relevance to wastewater disposal and re-use in agricultural 40 
settings due to CEC uptake and accumulation in food crops and consequent diffusion into the food-41 
chain, thus determining unintentional human exposure. This is the reason why the chemical CEC 42 
discussed in this review have been selected considering, besides recalcitrance, frequency of detection 43 
and entity of potential hazards, their relevance for crop uptake. Antibiotic-resistant bacteria (ARB) 44 
and antibiotic resistance genes (ARGs) have been also included as microbial CEC because of the 45 
potential of secondary wastewater treatment to offer conditions favourable to the survival and 46 
proliferation of ARB, as well as dissemination of ARGs. Given the adverse effects of chemical and 47 
microbial CEC, their removal is being considered as an additional design criterion, which highlights 48 
the necessity of upgrading of conventional WWTPs through the inclusion of more effective 49 
technologies. In this review, the performance of the currently applied biological treatment methods 50 
for secondary wastewater treatment is analysed. To this end, technological solutions including 51 
conventional activated sludge (CAS), membrane bioreactors (MBRs), moving bed biofilm reactors 52 
(MBBRs), and nature-based solutions such as constructed wetlands (CWs) are compared for the 53 
achievable removal efficiencies of the selected CEC and their potential of acting as reservoirs of 54 
ARB&ARGs. With the aim of giving a picture of real systems, this review focuses on data from full-55 
scale and pilot-scale plants treating real urban wastewater. To achieve an integrated assessment, 56 
technologies are compared considering also other relevant evaluation parameters of general validity, 57 
such as investment and management costs, complexity of layout and management, present scale of 58 
application and need of a post-treatment. The results of their comparison allow the definition of 59 
design and operation strategies for the implementation of CEC removal in WWTPs, when 60 
agricultural reuse of effluents is planned.  61 
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1. Introduction and objectives  89 
A discussion on the performance of technologies applied in wastewater treatment plants (WWTPs) 90 
for secondary treatment cannot disregard the presence of contaminants of emerging concern (CEC) 91 
in wastewaters, when assessing hazards to human health and ecosystems. According to the 92 
NORMAN network (2017), a CEC is “a substance currently not included in routine environmental 93 
monitoring programmes and may be candidate for future legislation due to its adverse effects and/or 94 
persistency”. Also, according to the United States Geological Survey (USGS) CEC include: “any 95 
synthetic or naturally occurring chemical or any microorganism that is not commonly monitored in 96 
the environment but has the potential to enter the environment and cause known or suspected 97 
adverse ecological and/or human health effects” (Klaper and Welch 2011).  98 
Currently, there is no standardized categorization of CEC, and generally, examined categories 99 
include among others, pharmaceuticals, personal care products, plasticizers, flame retardants, and 100 
pesticides. 101 
The release of CEC to the aquatic environment has been occurring for a long time, but suitable 102 
detection methods were not available until recently. As a result, nowadays we are able to identify and 103 
quantify these compounds. The synthesis of new chemicals, or changes in use and disposal of 104 
existing chemicals can create new sources of CEC into aquatic environments.  105 
_____________________________________________ 106 
Abbreviations: A2O, anaerobic–anoxic–oxic; ACTM, Acetamiprid; ARB, antibiotic resistant bacteria; ARGs, antibiotic resistance 107 
genes; AZM, Azithromycin; BDL, below detection limit; BHT, 2,6-Ditert-butyl-4-methylphenol; BOD, biochemical oxygen demand; 108 
BTA, Benzotriazole; CAS, conventional activated sludge; CBZ, Carbamazepine; CEC, contaminants of emerging concern; CIP, 109 
Ciprofloxacin; COD, chemical oxygen demand; CW, constructed wetland; Da, dalton; DCF, Diclofenac; DO, dissolved oxygen; DOC, 110 
dissolved organic carbon; E1, Estrone; E2, 17-Beta-estradiol; EE2, 17-Alpha-ethynylestradiol; EDG, electron donating functional 111 
groups; EHMC, 2-Ethylhexyl 4-methoxycinnamate; ENR, Enrofloxacin; ERY, Erythromycin; EWG, electron withdrawing functional 112 
groups; EU, European Union; F/M, Food to microorganisms ratio; HBCD, Hexabromocyclododecane; HGT, horizontal gene transfer; 113 
HRT, hydraulic retention time; IntI1, class 1 integron; Kbiol, kinetic reaction rate constant, L/gSS.d; Kd, solid-water partition coefficient, 114 
L/kgSS; Kow, octanol-water partition coefficient; LCA, life cycle assessment; MBBR, moving bed biofilm reactor; MBR, membrane 115 
bioreactor; MDR, multi-drug resistance; MF, microfiltration; MLSS, mixed liquor suspended solids; MLVSS, mixed liquor volatile 116 
suspended solids; MRSA, methicillin-resistant Staphylococcus aureus; N.A., not available; NDMA, N-Nitrosodimethylamine; 117 
NEREUS, COST Action ES1403 ‘New and emerging challenges and opportunities in wastewater reuse’; NORMAN, Network of 118 
reference laboratories, research centres and related organisations for monitoring of emerging environmental substances; NSAID, non-119 
steroidal anti-inflammatory compound; PCPs, personal care products; PE, population equivalent; PFBA, Perfluorobutanoic acid; 120 
PFHxA, Perfluorohexanoic acid; PFPeA, Perfluoropentanoic acid; QMRA, quantitative microbial risk assessment; q-PCR, quantitative 121 
polymerase chain reaction; SF CW, surface flow CWs; SMX, Sulfamethoxazole; SRT, sludge retention time; SWWTP, small WWTP 122 
of < 5.000 PE; TBBPA, Tetrabromobisphenol A; TCS, Triclosan; TCEP, Tris(2-chloroethyl)phosphate; TMP, Trimethoprim; TPs, 123 
transformation products; TSS, total suspended solids; UF, ultrafiltration; USGS, United States Geological Survey; VRE, Vancomycin-124 
resistant enterococci; WWTP, wastewater treatment plant. 125 
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In addition to the occurrence of chemical CEC in water environments, the widespread use and 126 
misuse of antibiotic residues and their uncontrolled emission in the environment was shown to 127 
contribute to the proliferation of antibiotic resistant bacteria (ARB) and their associated genes 128 
(antibiotic resistance genes, ARGs) (Berendonk et al., 2015), whose presence has been also detected 129 
in urban wastewater (Michael et al., 2013; Rizzo et al., 2013; Li et al., 2014a; Berglund et al., 2015; 130 
Xu et al., 2015). In this review, the latter are considered as microbial CEC. WWTPs can potentially 131 
reduce the emission of CEC including antibiotics. However, they also represent an important 132 
emission source of CEC to the receiving water bodies, due to the incomplete removal of a large 133 
number of these compounds. Moreover, WWTPs can act as collection points for ARB and 134 
antimicrobials from a variety of sources (i.e., hospitals, industries, households), consequently 135 
becoming point sources for environmental dissemination of antibiotic resistance (Pruden et al., 136 
2013). 137 
The above-mentioned aspects give an idea of the complexity of the issues arising from the presence 138 
of CEC in aquatic environments and antibiotic resistance-related problems. A wide spectrum of 139 
chemical and microbial contaminants with different physicochemical properties, toxicological 140 
characteristics and degree of potential risk must be managed, requiring suitable responses according 141 
to the applied treatment process. WWTPs are only partially effective in CEC removal or degradation, 142 
so these residual CEC are discharged into the environment with treated effluent and excess sludge. In 143 
an era of water scarcity, the presence of residual amounts of CEC in treated effluents is not only a 144 
problem for the environment but can also compromise treated wastewater reuse. 145 
The fate of CEC highly depends on the type of treatment applied at a specific WWTP. There are 146 
many factors determining the removal of specific classes of contaminants in WWTPs: compound 147 
chemical properties, plant configuration, hydraulic retention time (HRT), operating conditions (i.e. 148 
pH, temperature, etc), presence of industrial wastewater, etc. Furthermore, WWTPs commonly need 149 
to operate on a broad and heterogeneous group of contaminants in a wide range of influent 150 
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concentrations (varying from 0.001 to 1000 g/L) [based on Table 2 data]. Therefore, there is a need 151 
for technological solutions effective for various contaminants and under different operating 152 
conditions.  153 
The CEC have attracted the attention of the scientific community in the recent years, with many 154 
review papers addressing various aspects of CEC. These reviews were either focused on selected 155 
pharmaceutical compounds such as diclofenac, estrogens or antibiotics (Rivera-Utrilla et al., 2013; 156 
Vieno and Sillanpää 2014; Polesel et al., 2016; Schröder et al., 2016; Tiedeken et al., 2017) or on the 157 
selected treatment processes applied for CEC removal. Among these processes, membrane-based 158 
processes (Siegrist and Joss 2012; de Cazes et al., 2014; Li et al., 2015; Ojajuni et al., 2015; Shojaee 159 
Nasirabadi et al., 2016; Taheran et al., 2016; Kim et al., 2018), constructed wetlands (CWs) (Dordio 160 
and Carvalho 2013; Li et al., 2014b; Verlicchi and Zambello 2014; Zhang et al., 2014; Gorito et al., 161 
2017), biological processes such as conventional activated sludge (CAS), membrane bioreactors 162 
(MBRs), and bioelectrochemical systems (Verlicchi et al., 2012; Rojas et al., 2013; Vieno and 163 
Sillanpää 2014; Besha et al., 2017; Cecconet et al., 2017; Grandclément et al., 2017; Tiwari et al., 164 
2017), and various conventional and advanced processes such as advanced oxidation processes 165 
(AOPs) or activated carbon (Rivera-Utrilla et al., 2013; Luo et al., 2014; Barbosa et al., 2016; Bui et 166 
al., 2016; Hamza et al., 2016; Ahmed et al., 2017; Rodriguez-Narvaez et al., 2017; Tiedeken et al., 167 
2017; Yang et al., 2017) were reviewed. In addition, aspects such as the use of hybrid systems 168 
(Grandclément et al., 2017), impact on membrane fouling (Besha et al., 2017) sorption and 169 
biotransformation (Alvarino et al., 2018), geographical distribution (Tran et al., 2018), and 170 
comprehensive strategies for managing CEC (Talib and Randhir 2017) were also reviewed. 171 
The gaps that have been identified in these reviews were, among others, related to the significance 172 
and reliability of the collected CEC removal data being based on synthetic wastewater, small lab-173 
scale systems, specific industrial wastewaters and/or unsuitable sampling (Taheran et al. 2016, 174 
Cecconet et al. 2017, Grandclément et al. 2017, Tran et al. 2018). In addition, the need of a cost-175 
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benefit evaluation of the different treatment technologies (Bui et al. 2016, Grandclément et al. 2017) 176 
and the lack of information on design for optimum performance (Ahmed et al. 2017) were also 177 
pointed out. Furthermore, the general lack of knowledge on the occurrence of CEC in WWTP 178 
effluents and on the efficiency of different treatment methods (Schröder et al. 2016) as well as the 179 
need for intensification of technology-focused studies for effective and efficient control measures of 180 
CEC (Tiedeken et al. 2017), have been reported. One of the processes listed was a biofilm process, 181 
such as the moving bed biofilm reactor (MBBR) (Tran et al. 2018). Finally, due to the increasing 182 
importance of wastewater reuse as well as to the concern for antibiotic resistance spread from 183 
WWTPs effluents, there is a clear need to review the microbial CEC, namely ARB&ARGs and 184 
relevant aspects related to crop uptake.  185 
To this end, the aim of this review is to address these gaps and specifically: i) to give a picture of real 186 
applications by focusing on full-scale systems, ii) to analyse the performance of currently applied 187 
secondary biological treatment technologies (namely CAS, MBR and MBBR) and nature-based 188 
solutions (namely CWs) for the removal of CEC, iii) to summarize current knowledge on the 189 
occurrence of antibiotic resistance after biological treatment and on the potential for antibiotic 190 
resistance spread, and iv) to combine present findings on technical and economic considerations 191 
regarding the compared technologies as an attempt to provide input for a cost-benefit evaluation. 192 
Thus, the novelty of this paper predominantly lies in reviewing only full- and pilot-scale plants 193 
treating real urban wastewater, and including microbial CEC and crop uptake aspects, which are of 194 
relevance for wastewater reuse. Therefore, the performance of the investigated technologies is 195 
analysed for a group of target CEC relevant for wastewater reuse, including the compounds reported 196 
in the EU Watch list (Decision 2015/495/EU, (2015/495/EU) and others, which are relevant for crop 197 
uptake (Piña et al. 2018). This last factor is essential for reuse, because the CEC present in the 198 
treated wastewater that is used for irrigation, can accumulate in food crops, being the first link for 199 
CEC diffusion into the human food-chain, consequently being of relevance given the unintentional 200 
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human exposure. The prevalence of antibiotic resistance after biological treatment is also analysed to 201 
search for common trends regions on WWTPs potential for antibiotic resistance spreading, in spite of 202 
variables that may influence the outcomes, e.g. the operating conditions, plant configuration or 203 
geographic regions.  204 
 205 
2. Selection of CEC 206 
A list of 33 CEC was compiled for investigation in the present review: compounds were selected 207 
according to their relevance to wastewater reuse, in particular for potential uptake by crops, public 208 
health issues and/or environmental safety implications. In addition to this list of organic micro-209 
contaminants, also ARB&ARGs were included as CEC, an option that is justified by the critical 210 
relevance of these (micro)biological contaminants to public health and, above all, the recognized 211 
persistence and self-replication potential of these micro-contaminants in environmental 212 
compartments. The selection of specific organic and microbial CEC was based on the 213 
recommendations of the NEREUS COST Action ES 14031, a network of scientists and stakeholders 214 
interested in urban wastewater reuse from 42 countries. The NEREUS COST Action Working Group 215 
2 activities, focused on ‘Uptake and translocation of organic micro-contaminants and ARB&ARGs 216 
in crops’ identified and indicated compounds relevant to crop uptake. This list was combined with a 217 
list of compounds from the EU Watch List, recommended by the NEREUS COST Action Working 218 
Group 4, whose activities focused on ‘Technologies efficient/economically viable to meet the current 219 
wastewater reuse challenges’, due to their environmental and health relevant aspects.  220 
The following criteria reported in order of priority, were taken into account during the selection of 221 
the CEC for examination in this review.  222 
i.Uptake by crops. Once in the agricultural environment, CEC have the potential to be taken up by 223 
fodder and edible crops. The uptake of pharmaceuticals has been demonstrated by various authors 224 
 
1 COST Action ES1403 New and emerging challenges and opportunities in wastewater reuse (NEREUS), 
http://www.nereus-cost.eu 
9 
 
(Calderón-Preciado et al., 2013; Goldstein et al., 2014; Malchi et al., 2014; Christou et al., 2017; 225 
Christou et al., 2018). More specifically in a study by Calderón-Preciado et al., (2013), the uptake of 226 
various CEC and metabolites by lettuce, carrots, potatoes, tomatoes, cucumbers and green beans 227 
irrigated with reclaimed water has been examined. The results of these studies showed that non-ionic 228 
pharmaceuticals such as carbamazepine are taken up at higher concentrations compared to ionic 229 
compounds, by the examined plants. Moreover, the presence of carbamazepine metabolites in the 230 
leaves of carrots and potatoes at higher concentrations than the parent compound, suggests the 231 
occurrence of uptake and metabolic breakdown of carbamazepine inside the crop plants.  232 
ii.Effects on crop production. Plant exposure to CEC may affect plant development, either through 233 
direct contact and damage, or as the result of the action of pharmaceuticals on plant microbiota and 234 
soil microorganisms, so having a role in plant-microorganism symbioses and soil nutrient cycling 235 
(Peñuelas et al., 2013). Ferrari et al., (2003) investigated the effect of carbamazepine, diclofenac and 236 
clofibric acid residues found in irrigated wastewater on the microalga Pseudokirchinella subcapitata, 237 
demonstrating a reduction in growth in the algal nutrient solution in the presence of the CEC, at a 238 
concentration of 10 mg/L. In another study by Eggen et al., (2011), the effect of the uptake of 239 
metformin, ciprofloxacin and narasin (an anti-coccidial) in carrot and barley were investigated. The 240 
results showed negative effects on the growth of all plants investigated, when these were grown in 241 
soil, which contained a concentration of these CEC at 6 to 10 mg kg-1 dry weight. 242 
iii. Environmental- and human-health concern. The occurrence of CEC in environmental 243 
compartments has been often associated to a number of biological adverse effects, such as toxic 244 
effects, endocrine disruption and antibiotic resistance in microorganisms (Luo et al., 2014). Yet, the 245 
potential effects of CEC remain unclear and in need of further investigations (Ahmed et al., 2017). In 246 
2015, the European Commission established the EU Watch List (Decision (2015/495/EU) of 17 247 
substances for monitoring in water. Their inclusion has been justified by their potential to cause 248 
damage to aquatic environments and to pose a significant risk at European Union level, but for which 249 
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monitoring data are insufficient to come to a conclusion regarding the actual posed risk. These 250 
compounds belong to various categories such as estrogenic hormones, non-steroidal anti-251 
inflammatory compounds (NSAIDs), antibiotics, UV filters and antioxidant compounds, pesticides 252 
and herbicides. 253 
iv.Recalcitrance. Recalcitrant compounds, which remain practically unaltered during wastewater 254 
treatment, require special attention, as they may accumulate in environments receiving treated 255 
wastewater, and may thus pose a hazard to environmental health. For instance, Jones et al., (2017) 256 
investigated recently the fate of 95 CEC in 3 full-scale WWTPs after trickling filter treatment 257 
followed by nitrification, or after activated sludge treatment. Their results indicated that a group of 258 
compounds were recalcitrant to both treatments, as their removal varied from -58% to 14%. 259 
Azithromycin (total average removal of 14%), carbamazepine (1%) and estrone (13%) were among 260 
the recalcitrant CEC. Moreover, the antibiotic erythromycin was found to be recalcitrant during 261 
biological treatment according to various studies conducted in real wastewater effluents (Yang et al., 262 
2011; Guerra et al., 2014; Kim et al., 2014; Pasquini et al., 2014), indicating the importance of 263 
antibiotic monitoring in treated effluent receiving environments.  264 
v.Frequency of detection. Frequency of detection is an indicator of persistence and tolerance to 265 
biological treatment. For example, compounds like sulfamethoxazole, carbamazepine, diclofenac, 266 
estrone and estradiol showed high frequency of detection being present in all treated wastewater 267 
samples (n=16) of four WWTPs in southern California (Vidal‐Dorsch et al., 2012). Loos et al., 268 
(2013) found similar results in an EU-wide monitoring survey assessing the occurrence of polar 269 
chemical contaminants in effluents of 90 WWTPs. Carbamazepine and ciprofloxacin showed a 270 
frequency of 90%, and sulfamethoxazole and diclofenac were detected with a frequency of 83 and 271 
89% respectively. Metformin and benzotriazole were also detected in high concentrations exceeding 272 
1µg/L in the effluent during the screening of the Swiss WWTPs (Margot et al., 2013). 273 
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The list of the compounds examined in this review, based on the above selection criteria, is shown in 274 
Table 1.  275 
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 276 
Table 1. Properties, function of selected compounds and justification of their selection for the purposes of this review.  277 
 
Group 
Compound Acronym Structure2 
CAS 
number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
P
y
ri
m
id
in
e 
in
h
ib
it
o
r 
an
ti
b
io
ti
c 
Trimethoprim TMP 
 
738-70-5 0.91 290.32 Antibiotic 
Relevance for 
crop uptake 
M
ac
ro
li
d
e 
an
ti
b
io
ti
cs
 
Erythromycin ERY 
 
114-07-8 2.48-3.06 733.93 Antibiotic 
EU Watch List 
(Decision 
2015/495/EU) 
Clarithromycin CLR 
 
81103-11-9 3.16 747.95 Antibiotic 
EU Watch List 
(Decision 
2015/495/EU) 
Azithromycin AZM 
 
83905-01-5 4.02 748.98 Antibiotic 
EU Watch List 
(Decision 
2015/495/EU) 
 
2 http://www.chemspider.com  
3 Selected compounds are also indicators in Swiss water protection act to evaluate effectiveness of advanced treatment of wastewater (Carbamazepine, Clarithromycin, Diclofenac, 
Benzotriazole) or listed as priority hazardous substance in Norway (TCEP, TBBPA, HBCD, Triclosan). 
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Group 
Compound Acronym Structure2 
CAS 
number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
S
u
lf
o
n
am
id
e 
an
ti
b
io
ti
cs
 
Sulfamethoxazole SMX 
 
723-46-6 0.89-0.91 253.28 Antibiotic 
Relevance for 
crop uptake 
Q
u
in
o
lo
n
e 
an
ti
b
io
ti
cs
 
Enrofloxacin ENR 
 
93106-60-6 1.1 359.39 Antibiotic 
Relevance for 
crop uptake 
Ciprofloxacin CIP 
 
85721-33-1 0.28-0.40 331.34 Antibiotic 
Relevance for 
crop uptake 
P
h
ar
m
ac
eu
ti
ca
ls
 
Diclofenac DCF 
 
15307-86-5 4-4.5 296.15 
Non-steroidal 
anti-
inflammatory 
agent 
EU Watch List 
(Decision 
2015/495/EU), 
relevance for 
crop uptake 
Metformin MTF 
 
657-24-9 -2.48 129.16 
Antidiabetic 
drug 
Relevance for 
crop uptake 
Carbamazepine CBZ 
 
298-46-4 
85756-57-6 
2.45 236.27 
Antiepileptic 
drug 
Relevance for 
crop uptake 
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Group 
Compound Acronym Structure2 
CAS 
number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Lamotrigine LTG 
 
84057-84-1 1.19-2.12 256.09 
Anticonvulsant 
drug 
Relevance for 
crop uptake 
A
n
ti
m
ic
ro
b
ia
l 
 
ag
en
t 
Triclosan TCS 
 
3380-34-5 5.34 289.54 Antiseptic 
Relevance for 
crop uptake 
E
st
ro
g
en
s 
17-Alpha-
ethynylestradiol 
EE2 
 
57-63-6 
3.67-4.12-
4.2 
296.40 
Synthetic 
hormone 
EU Watch List 
(Decision 
2015/495/EU), 
relevance for 
crop uptake 
17-Beta-estradiol E2 
 
 
50-28-2 
 
3.94-4.01 272.38 
Natural 
hormone 
EU Watch List 
(Decision 
2015/495/EU), 
relevance for 
crop uptake 
Estrone E1 
 
53-16-7 3.13-3.43 270.37 
Natural 
hormone 
(breakdown 
product of E2) 
EU Watch List 
(Decision 
2015/495/EU) 
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Group 
Compound Acronym Structure2 
CAS 
number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
In
d
u
st
ri
al
 c
h
em
ic
al
s 
2,6-Ditert-butyl-4-
methylphenol 
BHT 
 
 
128-37-0 
3.5-5.1 220.35 
Antioxidant 
(food additive) 
EU Watch List 
(Decision 
2015/495/EU) 
Tris(2-
chloroethyl)phosp
hate 
TCEP 
 
115-96-8 1.44-1.6 285.49 
Flame retardant, 
plasticizer 
Relevance for 
crop uptake 
Tetrabromobisphe
nol A 
TBBPA 
 
79-94-7 
5.3-  
5.9 
543.87 
Brominated 
flame retardant 
Relevance for 
crop uptake 
Hexabromocyclod
odecane  
HBCD 
 
3194-55-6 5.07-5.47 641.69 
Brominated 
flame retardant 
Relevance for 
crop uptake 
Benzotriazole BTA 
 
95-14-7 1.44 119.13 
Corrosion 
inhibitor 
Relevance for 
crop uptake 
N-
Nitrosodimethyla
mine 
(dimethylnitrosam
ine) 
NDMA 
 
62-75-9 -0.57 74.08 
Industrial and 
chlorination by-
product  
Relevance for 
crop uptake 
16 
 
 
Group 
Compound Acronym Structure2 
CAS 
number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Perfluorobutanoic 
acid 
PFBA 
 
375-22-4 2.82 214.04 
Perfluorinated 
carboxylic acid 
(PFCA) 
Relevance for 
crop uptake 
Perfluoropentanoi
c acid 
PFPeA 
 
2706-90-3 3.43 264.05 
Perfluorinated 
carboxylic acid 
(PFCA) 
Relevance for 
crop uptake 
Perfluorohexanoic 
acid 
PFHxA 
 
307-24-4 4.06 314.05 
Perfluorinated 
carboxylic acid 
(PFCA) 
Relevance for 
crop uptake 
P
er
so
n
al
 c
ar
e 
p
ro
d
u
ct
s 
(P
C
P
s)
 
2-Ethylhexyl 4-
methoxycinnamat
e 
EHMC 
 
 
5466-77-3 5.8 
289.39 
290.40 
UV-filter/ 
stabilizer 
EU Watch List 
(Decision 
2015/495/EU) 
N
eo
n
ic
o
ti
n
o
id
s 
Imidacloprid IMI 
 
105827-78-
9/138261-
41-3 
0.57 255.66 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
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Group 
Compound Acronym Structure2 
CAS 
number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Thiacloprid THI 
 
111988-49-9 0.73-1.26 252.72 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Thiamethoxam TMX 
 
153719-23-4 -0.13 291.71 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Clothianidin CLO 
 
210880-92-5 0.7 249.68 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Acetamiprid ACTM 
 
135410-20-
7/160430-
64-8 
0.8 222.67 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
P
es
ti
ci
d
es
 
Methiocarb  
 
2032-65-7 2.92 225.31 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
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Group 
Compound Acronym Structure2 
CAS 
number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Oxadiazon  
 
19666-30-9 3.9-4.9 345.22 Herbicide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Triallate  
 
2303-17-5 4.6 304.66 Herbicide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
 278 
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3. Selection of secondary wastewater treatment technologies  279 
3.1 Criteria for selection  280 
The examined technologies applied in secondary wastewater treatment were selected according to 281 
their present level of application at full scale WWTPs, as well as to the state of knowledge of their 282 
performance for the removal of the selected CEC. The availability of reliable dataset for CEC was 283 
mandatory to this aim and, unfortunately, not so many data are available for technologies other than 284 
CAS and MBRs. Accordingly, the attention was mainly focused on these two treatment options. 285 
However, MBBRs, a potentially effective technology for CEC removal, and CWs, as a valid 286 
example of nature-based method characterized by easy installation and operation as well as good 287 
removal efficiencies for several CEC, were also introduced as potential promising alternatives to 288 
CAS and MBRs.  289 
 290 
3.2 Removal mechanisms of CEC for the selected treatment technologies 291 
For the CAS process, the main removal mechanisms of CEC are biodegradation (intended as 292 
complete mineralization of the compound) and sorption. Their occurrence and extent depend on the 293 
operating parameters of the plants i.e. SRT, Food to Microorganisms (F/M) ratio, presence of aerated 294 
and not aerated zones, pH and temperature. Previous studies found that long SRT have a positive 295 
effect on the removal of several compounds (Cirja et al., 2017), in particular on hormones and 296 
antibiotics, which are mainly removed by biodegradation (Strenn et al., 2004). This removal increase 297 
may be justified by the fact that long SRTs may promote growth of slow growing bacteria with 298 
various enzymes, which have been shown to have positive effects on removal of various CEC 299 
including diclofenac, erythromycin and 17α-ethynylestradiol (Suarez et al., 2010; Fernandez-300 
Fontaina et al., 2012). In addition, varying composition of the solid matrix and different sorption 301 
capacities due to high SRTs in conjunction with reduced F/M ratio may also increase microbial 302 
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diversity (Göbel et al., 2007). The influence of HRT has been a subject of discussion as it was 303 
reported to enhance some compounds degradation (Metcalfe et al., 2003; Gros et al., 2010) as well as 304 
to have negligible effect on removal of other compounds, e.g. diclofenac (Bernhard et al., 2006). 305 
Moreover, high biomass concentrations provide higher stability, persistence to shock loads, 306 
increased contact between microorganisms and pollutants, thus facilitating their biodegradation 307 
(Cirja et al., 2007; Verlicchi et al., 2012; Trinh et al., 2016a). This may also induce microorganisms 308 
metabolism of poorly degradable compounds due to relative shortages in biodegradable substances 309 
associated with reduced F/M ratio (Verlicchi et al., 2012). Suarez et al., (2010) classified CEC based 310 
on the removal potential under different biological conditions: i) highly removed under aerobic and 311 
anoxic conditions (e.g., ibuprofen, fluoxetine, natural estrogens); ii) highly removed under aerobic 312 
but persistent under anoxic conditions (e.g., diclofenac, 17α-ethynylestradiol, erythromycin), and iii) 313 
refractory to biological transformation (e.g., sulfamethoxazole, carbamazepine). Finally, temperature 314 
of wastewater as well as seasonal temperature changes play a role in the removal of CEC, as better 315 
removal is obtained at temperatures of 15–20°C compared to below 10°C (Vieno et al., 2005; 316 
Castiglioni et al., 2006).  317 
Biodegradation and sorption are also the main CEC removal mechanisms in MBRs (Radjenović et 318 
al., 2008; Verlicchi et al., 2012; Luo et al., 2014; Li et al., 2015). This is because of the low 319 
molecular size of most CEC, typically below 1000 dalton, which leads to no direct physical retention 320 
on MF (microfiltration) and UF (ultrafiltration) membranes (retention size of ca. 10 000-500 000 321 
Da). However, the sludge deposits formed on the membrane surface can act as an additional barrier 322 
contributing to the removal of CEC (Li et al., 2015). Furthermore, the hydrophobicity of CEC 323 
influences CEC sorption and removal. The removal is improved when the compound is significantly 324 
hydrophobic (log Kow>3), such as the case of diclofenac, EE2, E2, EHMC, azithromycin, triallate 325 
and oxadiazon (Phan et al., 2014). Otherwise, sorption onto biosolids is limited and biodegradation is 326 
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the dominant removal mechanism. Variable removal efficiencies have been reported in MBRs for 327 
persistent compounds, including diclofenac and carbamazepine, which have low kbiol and low Kd 328 
values (Wijekoon et al., 2013). Despite the agreement on the higher removal of hydrophobic 329 
compounds and containing electron donating functional groups (EDG) compared to the compounds 330 
with opposite characteristics by MBRs, there is still a lack of understanding on the complete causes 331 
of removal of CEC and their transformation products (TPs) in MBRs (Reif et al., 2013). Concerning 332 
the effect of the operating parameters on CEC removal in MBRs, similarly to CAS, Li et al., (2015) 333 
concluded that higher SRT, lower pH, higher nitrogen loading rate, and anoxic conditions favour 334 
removal of some pharmaceutical micropollutants in MBRs. 335 
In CWs, a combination of physical, chemical, and biological processes may occur simultaneously 336 
and contribute to CEC removal. These include photodegradation, volatilization, phytoremediation, 337 
adsorption and sedimentation, as well as microbial biodegradation (Matamoros et al., 2005; Hijosa-338 
Valsero et al., 2010a; Reyes-Contreras et al., 2012; Li et al., 2014b). First, photodegradation is an 339 
important removal pathway for CEC in CW systems with free water surface, i.e. surface flow CWs 340 
(Andreozzi et al., 2003). Seasonal variations leading to lower light availability, lower light intensity, 341 
or stronger light attenuation with increasing water depth will reduce photodegradation efficiency in 342 
aquatic systems (Buser et al., 1998; Matamoros et al., 2008). These parameters will also affect 343 
removal of compounds with high volatilization potential. Secondly, the plants in CWs can directly 344 
uptake and translocate CEC (Dordio et al., 2009; Dordio et al., 2010; Hijosa-Valsero et al., 2010b; 345 
Hijosa-Valsero et al., 2011a; Carvalho et al., 2014). This uptake and translocation is most likely 346 
driven by diffusion, as no specific transporters exist within plants to move CEC into plant tissues 347 
(Dordio and Carvalho 2013). In addition, CEC can be transformed to less toxic compounds during 348 
metabolization in plants (Salt et al., 1998; He et al., 2017). Furthermore, the substrate of a CW (the 349 
CWs filling) can support growth of microorganisms and plants, and can adsorb different compounds, 350 
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including CEC. Substrates with a greater adsorption capability for CEC can significantly enhance 351 
CEC removal (Dordio et al., 2007; Bui and Choi 2010; Conkle et al., 2010).  352 
In MBBRs, the main removal mechanism is biodegradation. The amount of CEC eliminated with 353 
excess sludge withdrawal is lower than with CAS system as MBBRs work at a very low organic 354 
load. As mentioned in the CAS section above, SRT is as an important operational parameter for the 355 
removal of several micropollutants (Strenn et al., 2004). The agglomeration of bacteria as a biofilm 356 
and the retention of the support media for the attached growth process in the biological reactor 357 
results in long SRT. The geometry of the support media for bacterial growth allows the development 358 
of thin (~50 µm) or thick (> 200 µm) biofilms with different density, biodiversity composition, 359 
microbial activity and redox conditions (Torresi et al., 2017). Thin biofilms result in high nitrifying 360 
activities (enhancement of biotransformation kinetic of diclofenac, sulfamethoxazole, erythromycin, 361 
atenolol) while thick biofilms have a high bacterial biodiversity (more than 60% of target 362 
compounds showed higher biotransformation kinetics). Thus, combining the more suitable media 363 
and operational conditions lead the MBBR process to enhance specific or overall CEC elimination.  364 
 365 
4. Effects of secondary treatments on chemical CEC fate 366 
4.1 Influent characterization 367 
To evaluate the performance of the analyzed technologies it is important to have information on the 368 
CEC concentrations present in WWTPs influents. These concentrations are relevant for the 369 
determination of the efficiency of the applied technology. Data available for the selected compounds 370 
are reported in supplementary material Table SM1, while the range of concentrations is reported in 371 
Feil! Fant ikke referansekilden.. A variable range, from a few ng/L to several µg/L, is observed, 372 
which makes necessary to evaluate, case by case, the effluent quality and the related CEC emissions.  373 
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Table 2. Concentration range of the selected CEC in municipal wastewater before treatment.  374 
Category Concentration 
range (ng/L) 
Reference 
Antibiotics 
Trimethoprim 13-6000 (Gobel et al., 2005; Perez et al., 2005; Leung et al., 2012; Senta et al., 
2013; Guerra et al., 2014; Carvalho and Santos 2016; Botero-Coy et 
al., 2018) 
Erythromycin 17-320 (Yang and Carlson 2004; Gobel et al., 2005; Gros et al., 2006; 
Papageorgiou et al., 2016; Botero-Coy et al., 2018) 
Clarithromycin BDL-8000 (Loganathan et al., 2009; Margot et al., 2013; Birošová et al., 2014; 
Guerra et al., 2014; Tran et al., 2018) 
Azithromycin BDL-6810 (Gobel et al., 2005; Loganathan et al., 2009; Margot et al., 2013; 
Senta et al., 2013; Botero-Coy et al., 2018) 
Sulfamethoxazole BDL-3100  (Gobel et al., 2005; Perez et al., 2005; Gros et al., 2006; Margot et al., 
2013; Zhou et al., 2013; Guerra et al., 2014; Papageorgiou et al., 
2016) 
Enrofloxacin 3-100 (Watkinson et al., 2007; Ghosh et al., 2009; Birošová et al., 2014) 
Ciprofloxacin 15-3350 (Watkinson et al., 2007; Margot et al., 2013; Zhou et al., 2013; He et 
al., 2015; Botero-Coy et al., 2018)  
Other pharmaceuticals/antimicrobials  
Diclofenac  50-4114 (Clara et al., 2005b; Gros et al., 2006; Margot et al., 2013; Sari et al., 
2014) 
Metformin BDL->10000 (Margot et al., 2013; Kosma et al., 2015)  
Carbamazepine 54-1850 (Clara et al., 2005b; Nakada et al., 2006; Margot et al., 2013) 
Lamotrigine 13-1110 (Bollmann et al., 2016; Zonja et al., 2016) 
Triclosan  500- 6100 
 
(Lindstrom et al., 2002; Singer et al., 2002; Halden and Paull 2005; 
Ying and Kookana 2007) 
Industrial Chemicals 
2,6-Ditert-butyl- 
4-methylphenol(BHT) 
2420 (Liu et al., 2015) 
Tris(2-chloroethyl) 
 phosphate (TCEP) 
180-439 (Meyer and Bester 2004; Ryu et al., 2014; Zeng et al., 2015; Cristale 
et al., 2016) 
Tetrabromobisphenol A 1.22x10-4-41  (Morris et al., 2004; Potvin et al., 2012; Kim et al., 2016) 
Hexabromocyclododecane  1.2-11 (Vieno and Toivikko 2014; De Guzman 2016) 
24 
 
(HBCD)  
Benzotriazole (BTA) 1119- 44000  (Reemtsma et al., 2010; Liu et al., 2012; Asimakopoulos et al., 2013) 
N-Nitrosodimethylamine  
(dimethyl-nitrosamine) 
183-8230 (Yoon et al., 2011; Wang L. 2014) 
Perfluorobutanoic acid  
(PFBA) 
0.05-265 (Zhang et al., 2013; Zhang et al., 2015a) 
Perfluoropentanoic acid  
(PFPeA) 
0.5- 1520 (Lin et al., 2010; Ma and Shih 2010; Pan et al., 2011; Kim et al., 
2012; Zhang et al., 2013; Zhang et al., 2015a) 
Perfluorohexanoic acid 
(PFHxA) 
 1-348 (Lin et al., 2010; Ma and Shih 2010; Kim et al., 2012; Zhang et al., 
2013; Zhang et al., 2015a) 
Estrogens 
Estrone (E1) 11.6-224 (Zhou et al., 2012; Margot et al., 2013; Ekpeghere et al., 2018) 
17-Estradiol (E2) 3.7-140 (Zhou et al., 2012; Margot et al., 2013; Ekpeghere et al., 2018) 
17-Ethynylestradiol (EE2) BDL-330 (Zhou et al., 2012; Margot et al., 2013; Ekpeghere et al., 2018) 
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
23-1290 (Tsui et al., 2014; Ekpeghere et al., 2016) 
Neonicotinoids 
Imidacloprid 54.7 (Sadaria et al., 2016) 
Thiacloprid BDL (Sadaria et al., 2016) 
Thiamethoxam BDL (Sadaria et al., 2016) 
Clothianidin 149.7 (Sadaria et al., 2016) 
Acetamiprid 3.7 (Sadaria et al., 2016) 
 
Pesticides 
Methiocarb N.A.   
Oxadiazon N.A.  
Triallate N.A.  
Legend: BDL - below detection limit; N.A. – not available. 
 
 375 
 376 
  377 
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4.2 Conventional activated sludge 378 
Data available on the removal efficiencies detected for CAS are mainly related to pharmaceuticals 379 
(by far the most investigated class of CEC), personal care products and endocrine disruptor 380 
compounds.     381 
The high concentrations especially for some pharmaceuticals reported in Feil! Fant ikke 382 
referansekilden. show that, even when high removal efficiencies are achieved, consistent residual 383 
amounts will remain in the effluent which can significantly impact the receiving water body or 384 
compromise treated wastewater reuse.  385 
Table 3 shows an overview of the data on the removal efficiencies for the selected CEC in secondary 386 
treatment by CAS. Reported data are mainly referring to the last decade. A high variability in the 387 
removal efficiencies is observed, which can be explained with the seasonal variation of the plant 388 
performance and the variability of the CEC influent concentrations. Moreover, the presence of very 389 
low concentrations, which, in some cases, are close or below detection limits, makes the evaluation 390 
of a precise removal efficiency difficult. A more detailed and extended table (Table SM2) on the 391 
removal efficiencies is included in supplementary material. 392 
According to the results of a Canadian survey of 18 WWTPs (Metcalfe et al., 2003), primary 393 
treatment resulted in minimal reductions of CEC, while better results were observed for the 394 
secondary. It is worth noting that in several cases negative removals were observed, which are 395 
indicative of formation of parent compounds e.g., through de-conjugation, or accumulation of the 396 
substances during treatment, especially if sampling was carried out during non-steady-state plant 397 
operation. In addition, effluent quality can be worsened by the formation of intermediate products in 398 
case of partial biodegradation.  399 
26 
 
Among the selected pharmaceuticals, the neutral drug carbamazepine was poorly removed by the 400 
secondary treatment. It resulted as one of the most critical compounds, among the monitored 401 
pharmaceuticals, in all countries. This behaviour may be due to its hydrophilic nature (logKow <3) 402 
and chemical stability (Nakada et al., 2006). Similar behaviour is observed for lamotrigine which, in 403 
two recent studies (Bollmann et al., 2016; Zonja et al., 2016), showed a consistent concentration 404 
increase in the effluent.  405 
For the selected antibiotics, highest removal efficiencies were detected for ciprofloxacin and 406 
sulfamethoxazole, while the other antibiotics are characterized by quite low removals.  407 
As regard as the estrogenic compounds, higher removal efficiencies were observed for the hormone 408 
17β-estradiol than for estrone (Zhou et al., 2012). Secondary treatment can reach removal 409 
efficiencies ≥ 90% for estrogenic compounds but only in WWTPs performing nitrification or 410 
nitrogen removal (Andersen et al., 2003). This is because high HRT and SRT are required for 411 
efficient estrone removal, as it is confirmed by Margot et al., (2013) reporting the data of the 412 
Lausanne plant (operated without nitrification) where the removal of 17β-estradiol and estrone was 413 
91% and 58±31%, respectively. 414 
Not many data are available for EHMC removal and neonicotinoids in CAS. Tsui et al., (2014) for a 415 
WWTP operated with Modified Ludzack Ettinger configuration, reported low to moderate removal 416 
of EHMC, i.e., 30% in the wet season and 55% in the dry season, which was negatively affected by 417 
seasonal variation of the influent load and temperature during the wet season. As regard as 418 
neonicotinoids, Sadaria et al., (2016) in a recent study on a WWTP measured low removal 419 
efficiencies of 11-18% for the selected compounds except for thiacloprid and thiamethoxam showing 420 
negligible concentration (BDL) in the influent and effluent.  421 
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Pesticides are among the organic contaminants most investigated in the aquatic environment, but 422 
their occurrence and fate in WWTPs has been rarely investigated, perhaps because these compounds 423 
are of agricultural rather than of urban origin. In spite of this, wastewaters represent one of the main 424 
routes of pesticide contamination into the environment (Cahill et al., 2011) and several sources 425 
justifying the presence of pesticides in WWTPs were identified. They are extensively applied in 426 
grass-maintenance, in industrial vegetation control for electric utilities, roadways, railroads, 427 
pipelines, and in non-agricultural crops such as commercial forestry and horticulture (Barceló D 428 
2003). For these reasons, to our best knowledge data on these specific compounds in the target list 429 
are not available in literature. In any case, it is worth noting that the reported removals of pesticides 430 
in full-scale WWTPs are generally poor with presence, in some cases, of increased concentrations in 431 
the effluent (Kock-Schulmeyer et al., 2013).  432 
An extremely variable behaviour in WWTPs is observed for industrial chemicals with almost 433 
complete/good removal for instance for BHT, TBBP-A, BTA, and wide range of removal efficiency 434 
for other compounds such as PFCAs (PFBA, PFPeA, PFHxA) and NDMA. This finding is expected 435 
if we consider the diversity of the chemical structure, which as pointed out in the paragraph 4.1 436 
consistently affects the removal mechanisms.   437 
From the data analysis of CAS, we can conclude that CEC removal efficiency is strongly affected by 438 
HRT and SRT. To give a general idea of the limit values, according to Metcalfe et al., (2003), worst 439 
performance is observed in plants having HRT ≤ 7 hr and SRT ≤ 1.9 d.  440 
  441 
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 442 
Table 3. Range of the removal efficiencies of the selected CEC in CAS plants  443 
Category Removal 
efficiency (%) 
Reference 
Antibiotics 
Trimethoprim 31 (Gobel et al., 2005) 
Erythromycin (-14)-100  (Yang and Carlson 2004; Gobel et al., 2005; Gros et al., 2006) 
Clarithromycin 37 (Margot et al., 2013) 
Azithromycin 11-44 (Gobel et al., 2005; Loganathan et al., 2009; Margot et al., 2013) 
Sulfamethoxazole 35-84 (Gobel et al., 2005; Margot et al., 2013; Zhou et al., 2013) 
Enrofloxacin ~ 0 (Watkinson et al., 2007) 
Ciprofloxacin 63-90 (Margot et al., 2013; Zhou et al., 2013) 
Other pharmaceuticals/antimicrobials 
Diclofenac  <0-81 
 
(Clara et al., 2005b; Margot et al., 2013; Luo et al., 2014; Sari et 
al., 2014) 
Metformin 78-99 (Kosma et al., 2015) 
Carbamazepine (-90)-(-3)  
 
(Metcalfe et al., 2003; Clara et al., 2005b; Nakada et al., 2006; 
Margot et al., 2013) 
Lamotrigine (-361)-(-38) (Bollmann et al., 2016; Zonja et al., 2016) 
Triclosan 34-99  (Lindstrom et al., 2002; Singer et al., 2002; Halden and Paull 2005; 
Ying and Kookana 2007) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
89 (Liu et al., 2015) 
Tris(2-chloroethyl) 
phosphate (TCEP) 
(-106)-0 (Meyer and Bester 2004; Ryu et al., 2014; Zeng et al., 2015; 
Cristale et al., 2016) 
Tetrabromobisphenol A 10-100 (Potvin et al., 2012; Kim et al., 2016) 
Hexabromocyclododecane 
(HBCD) 
0-86 (Vieno and Toivikko 2014; De Guzman 2016)  
Benzotriazole (BTA) 30-91 (Reemtsma et al., 2010; Liu et al., 2012; Asimakopoulos et al., 
2013) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
5-84  (Yoon et al., 2011; Wang L. 2014) 
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Perfluorobutanoic acid 
(PFBA) 
(-108)-65 (Zhang et al., 2013; Zhang et al., 2015a) 
Perfluoropentanoic acid 
(PFPeA) 
(-400)-50 (Pan et al., 2011; Kim et al., 2012; Zhang et al., 2013; Zhang et al., 
2015a) 
Perfluorohexanoic acid 
(PFHxA) 
(-226)-39 (Kim et al., 2012; Zhang et al., 2013; Zhang et al., 2015a) 
Estrogens 
Estrone (E1) 58-81 (Zhou et al., 2012; Margot et al., 2013) 
17-Estradiol (E2) 91-96 (Zhou et al., 2012; Margot et al., 2013) 
17-Ethynylestradiol 
(EE2) 
>18-94 
 
(Zhou et al., 2012; Margot et al., 2013) 
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
30-55 (Tsui et al., 2014) 
Neonicotinoids 
Imidacloprid 11  (Sadaria et al., 2016) 
Thiacloprid BDL in/out (Sadaria et al., 2016) 
Thiamethoxam BDL in/out (Sadaria et al., 2016) 
Clothianidin 13 (Sadaria et al., 2016) 
Acetamiprid 18 (Sadaria et al., 2016) 
Pesticides 
Methiocarb 
Oxadiazon 
Triallate 
N.A. 
N.A. 
N.A. 
 
  444 
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4.3 Membrane bioreactors 445 
The MBR is a process that integrates biodegradation of contaminants by activated sludge, with direct 446 
solid-liquid separation by membrane filtration, i.e. through a MF or UF membrane. The MBR 447 
technology is currently widely accepted as an alternative key technology to CAS treatment utilised in 448 
urban WWTPs and water reuse applications. The wide use of MBRs has been attributed to its notable 449 
advantages, such as high quality of produced water, high biodegradation efficiency of contaminants, 450 
and an overall smaller footprint (Judd, 2015).  451 
This technology permits bioreactor operation with considerably higher mixed liquor suspended 452 
solids (MLSS) concentration than CAS systems, which are limited by sludge settling phenomena. 453 
The process in MBRs is typically operated at MLSS in the range of 8–12 g/L, while CAS is operated 454 
in the range of 2–3 g/L (Melin et al. 2006), thus providing high biological activity per unit volume. 455 
This feature favours the generation of slow-growing bacteria, which have the ability to degrade 456 
certain biologically-recalcitrant organic and inorganic pollutants (Clouzot et al., 2011). Therefore, 457 
despite not been designed to remove organic and inorganic micropollutants, MBRs may provide 458 
effective removal of some of the CEC. Early studies reported improved CEC removal with MBRs 459 
compared to CAS, as MBRs operate at a higher SRT than CAS, thus enhancing contaminant 460 
biodegradability (Holbrook et al., 2002; Stephenson et al., 2007). However, when MBRs and CAS 461 
were compared under similar operating conditions (i.e., SRT, temperature) in the removal of CEC, 462 
no significant differences were observed (Joss et al., 2006; Bouju et al.m 2008; Weiss and 463 
Reemtsma, 2008; Abegglen et al., 2009). Therefore, it was postulated that MBRs and CAS systems 464 
may perform similar as long as the same operating conditions are provided, although MBRs may 465 
outperform CAS at higher SRT. This is because CEC are generally highly soluble and relatively 466 
small compounds, typically below 1000 Dalton, which can freely pass through the membranes used 467 
in MBR systems thereby indicating that those membranes have no direct impact on the removal of 468 
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CEC (Snyder et al., 2007). Others report that MBRs are able to effectively remove a wide spectrum 469 
of CEC including compounds that are not eliminated during CAS processes (Radjenović et al., 2009; 470 
Luo et al., 2014).  471 
Overall, the potential to achieve slightly improved removal of CEC in MBRs compared to the CAS 472 
process, is attributed to: (1) complete retention of suspended and colloidal particles to which many of 473 
the CEC sorb or are entrapped at the cake layer developed on the membrane surface; (2) ability to 474 
operate under longer SRT providing additional biological transformation of CEC (via diversification 475 
of microorganisms metabolic activity in response to the lower sludge loading with bulk organics) 476 
and more diversified microbial community (e.g. nitrifying bacteria); and (3) higher biomass 477 
concentrations providing higher degradation rate. All of the aforementioned factors may provide 478 
additional removal mechanisms of CEC. On the other hand, the advantage of operating MBRs at 479 
very high SRT to promote the biodegradation of recalcitrant compounds is usually offset by the 480 
increased operating costs associated with the higher oxygen requirements of biomass. Hence, despite 481 
significant research attention in the past years, general consensus regarding the MBRs and CAS 482 
potential to remove CEC has not been reached yet.  483 
Table 4 summarizes the removal efficiency of the selected CEC (Hernando et al., 2007; Onesios et 484 
al., 2008; Petrovic et al., 2009; Tambosi et al., 2010b; Verlicchi et al., 2012; Reif et al., 2013; Rojas 485 
et al., 2013; de Cazes et al., 2014; Luo et al., 2014; Eggen and Vogelsang 2015; Li et al., 2015). The 486 
overview excludes the experimental work carried out using lab-scale MBR systems fed with 487 
synthetic wastewater, and reports only results from full-scale MBRs or pilot-scale MBRs located at 488 
the premises of the WWTPs and fed with real wastewater. Until now, only a limited number of the 489 
studies were performed on full-scale MBR installations (Sui et al., 2011; Trinh et al., 2012b; 490 
Oosterhuis et al., 2013; Fenu et al., 2015; Trinh et al., 2016b). 491 
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A more detailed table including the operating conditions of the WWTPs and on the type of 492 
wastewater and sampling methods is reported in the supplementary material section (Table SM3). 493 
  494 
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Table 4. Range of the removal efficiencies of the selected CEC in MBRs   495 
Category Removal 
efficiency (%) 
References 
Antibiotics 
Trimethoprim <0-99 (Göbel et al., 2007; Kim et al., 2007; Snyder et al., 2007; Tambosi et al., 
2010a; Sahar et al., 2011a; Sahar et al., 2011b; Sahar et al., 2011c; Sui et 
al., 2011; Schröder et al., 2012; Trinh et al., 2012b; Qi et al., 2015; 
Arriaga et al., 2016; Tran et al., 2016; Trinh et al., 2016b; Arola et al., 
2017; Park et al., 2017) 
Erythromycin 4-99 (Kim et al., 2007; Radjenovic et al., 2007; Snyder et al., 2007; Barceló et 
al., 2009; Radjenovic et al., 2009; Xue et al., 2010; Sahar et al., 2011a; 
Sahar et al., 2011b; Sahar et al., 2011c; Dolar et al., 2012; Malpei et al., 
2012; Kim et al., 2014; Qi et al., 2015; Arriaga et al., 2016; Mamo et al., 
2016; Tran et al., 2016) 
Clarithromycin <0-99 (Göbel et al., 2007; Sahar et al., 2011a; Sahar et al., 2011b; Sahar et al., 
2011c; Dolar et al., 2012; Malpei et al., 2012; Kim et al., 2014; Qi et al., 
2015; Arriaga et al., 2016; Mamo et al., 2016; Tran et al., 2016; Park et 
al., 2017) 
Azithromycin 5-90 (Göbel et al., 2007; Dolar et al., 2012; Kim et al., 2014; Mamo et al., 
2016; Tran et al., 2016) 
Sulfamethoxazole 0-90 (Kreuzinger et al., 2004; Clara et al., 2005b; Joss et al., 2005; Göbel et al., 
2007; Kim et al., 2007; Radjenovic et al., 2007; Barceló et al., 2009; 
Radjenovic et al., 2009; Le-Minh et al., 2010:Snyder, 2007 #1635; 
Tambosi et al., 2010a; Sahar et al., 2011a; Sahar et al., 2011b; Sahar et 
al., 2011c; Dolar et al., 2012; García Galán et al., 2012; Schröder et al., 
2012; Trinh et al., 2012b; Kim et al., 2014; Fenu et al., 2015; Phan et al., 
2015; Qi et al., 2015; Tran et al., 2016; Trinh et al., 2016b; Park et al., 
2017) 
Enrofloxacin <LOQ-56 (Baumgarten et al., 2007; Park et al., 2017) 
Ciprofloxacin 15-94 (Baumgarten et al., 2007; Malpei et al., 2012; Kim et al., 2014; Tran et 
al., 2016; Park et al., 2017) 
Other pharmaceuticals/antimicrobials 
Diclofenac <0-87 (Clara et al., 2005a; Clara et al., 2005b; Kimura et al., 2005; Quintana et 
al., 2005; Bernhard et al., 2006; González et al., 2006; Kim et al., 2007; 
Kimura et al., 2007; Radjenovic et al., 2007; Snyder et al., 2007; Pérez 
and Barceló 2008; Barceló et al., 2009; Radjenovic et al., 2009; Xue et 
al., 2010; Sahar et al., 2011a; Sui et al., 2011; Lipp et al., 2012; Malpei et 
al., 2012; Trinh et al., 2012b; Cartagena et al., 2013; Oosterhuis et al., 
2013; Phan et al., 2015; Qi et al., 2015; Arriaga et al., 2016; Trinh et al., 
2016b; Arola et al., 2017; Park et al., 2017; Tran and Gin 2017) 
Metformin 94-99 (Trinh et al., 2012b; Oosterhuis et al., 2013; Kim et al., 2014) 
Carbamazepine <0-96 (Kreuzinger et al., 2004; Clara et al., 2005a; Clara et al., 2005b; Joss et 
al., 2005; Bernhard et al., 2006; Kim et al., 2007; Radjenovic et al., 2007; 
Snyder et al., 2007; Barceló et al., 2009; Radjenovic et al., 2009; Xue et 
al., 2010; Sui et al., 2011; Dialynas and Diamadopoulos 2012; Dolar et 
al., 2012; Lipp et al., 2012; Malpei et al., 2012; Trinh et al., 2012b; 
Cartagena et al., 2013; Oosterhuis et al., 2013; Kim et al., 2014; Komesli 
et al., 2015; Phan et al., 2015; Qi et al., 2015; Arriaga et al., 2016; Arola 
et al., 2017; Park et al., 2017; Tran and Gin 2017) 
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Lamotrigine 0-84 (Bollmann et al., 2016) 
Triclosan 41-96 (Kim et al., 2007; Snyder et al., 2007; Kantiani et al., 2008; Coleman et 
al., 2009; Trinh et al., 2012b; Cartagena et al., 2013; Tran et al., 2016; 
Trinh et al., 2016b) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
N.A.  
Tris(2-chloroethyl) 
phosphate (TCEP) 
<0-37 (Bernhard et al., 2006; Kim et al., 2007) 
Tetrabromobisphenol A 62-90 (Potvin et al., 2012) 
Hexabromocyclododecane 
(HBCD) 
N.A.  
Benzotriazole (BTA) 15-74 (Weiss and Reemtsma 2008; Sahar et al., 2011b; Qi et al., 2015; Arriaga 
et al., 2016) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
70-94 (Gerrity et al., 2015; Mamo et al., 2016) 
Perfluorobutanoic acid 
(PFBA) 
11 (Pan et al., 2016) 
Perfluoropentanoic acid 
(PFPeA) 
<0 (Pan et al., 2016) 
Perfluorohexanoic acid 
(PFHxA) 
<0 (Pan et al., 2016) 
Estrogens 
Estrone (E1) 58-100 (Joss et al., 2004; Clara et al., 2005a; Joss et al., 2005; Zuehlke et al., 
2006; Coleman et al., 2009; Le-Minh et al., 2010; Xue et al., 2010; Cases 
et al., 2011; Wu et al., 2011a; Trinh et al., 2012a; Trinh et al., 2012b; He 
et al., 2013; Phan et al., 2015; Trinh et al., 2016b) 
17-Estradiol (E2) 39-100 (Joss et al., 2004; Clara et al., 2005a; Zuehlke et al., 2006; Lee et al., 
2008; Le-Minh et al., 2010; Xue et al., 2010; Wu et al., 2011a; Dialynas 
and Diamadopoulos 2012; Trinh et al., 2012a; Trinh et al., 2012b; He et 
al., 2013; Trinh et al., 2016b) 
17-Ethynylestradiol 
(EE2) 
20-100 
 
(Clara et al., 2004; Joss et al., 2004; Kreuzinger et al., 2004; Clara et al., 
2005a; Zuehlke et al., 2006; Le-Minh et al., 2010; Xue et al., 2010; Wu et 
al., 2011b; Dialynas and Diamadopoulos 2012; He et al., 2013; Trinh et 
al., 2016b)  
Personal care products 
2-Ethylhexyl 
ethoxycinnamate (EHMC) 
N.A.  
Neonicotinoids 
Imidacloprid N.A.  
Thiacloprid N.A.  
Thiamethoxam N.A.  
Clothianidin N.A.  
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Acetamiprid N.A.  
Pesticides 
Methiocarb N.A.  
Oxadiazon N.A.  
Triallate N.A.  
 496 
 497 
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4.4 Constructed Wetlands  498 
Constructed wetlands (CWs) are treatment systems that use natural processes involving wetland 499 
vegetation, soils, and their associated microbial assemblages. As nature-based solutions, CWs have 500 
the potential to address societal and economical challenges related to safe water reuse. If well 501 
designed and maintained, CWs may provide effluents suitable for water reuse (Rousseau et al., 502 
2008).  503 
CWs are mainly used to efficiently remove organic matter, suspended solids, nutrients, and some 504 
metals from wastewater, and in recent years, CWs have been used also to remove organic pollutants, 505 
such as pesticides (Matamoros and Salvadó 2012), hydrocarbons (Guittonny-Philippe et al., 2015) 506 
and a few CEC (Gorito et al., 2017). Currently, CWs are recognized as a reliable wastewater 507 
treatment technology, representing a suitable solution for the treatment of many types of 508 
wastewaters, such as municipal or domestic wastewaters, storm water, agricultural wastewaters and 509 
industrial wastewaters (such as petrochemicals, pulp and paper, food wastes and mining industries) 510 
(Vymazal 2011a). Furthermore, due to their simple set-up and low maintenance, CWs can be used in 511 
rural areas, where the treated water can be reused in agriculture. 512 
CWs are applied as a secondary treatment of municipal wastewater in relatively small communities, 513 
i.e. up to 1000 population equivalent (PE), but can also be used for the treatment of wastewater from 514 
greater areas covering 2000 PE (or more) (Vymazal 2011b). A limitation of the use of CWs for large, 515 
urbanized areas is associated with the higher area demand for these systems in comparison to the 516 
techniques based on activated sludge. Various examples exist on the removal of CEC in secondary 517 
treatments (Table 5 and Table SM4), and only a few applications of CWs for removing CEC during 518 
the polishing of wastewater effluent as a tertiary treatment are reported (Dordio et al., 2007; Imfeld 519 
et al., 2009; Bui and Choi 2010; Bhatia and Goyal 2014; Garcia-Rodríguez et al., 2014).  520 
The removal efficiencies of the tested CEC are seasonally variable, with higher removal percentages 521 
in summer compared to winter (Garcia-Rodríguez et al., 2014; Li et al., 2014b). Furthermore, 522 
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different designs exist, such as surface flow CWs (SF CWs), and sub-surface flow CWs with 523 
horizontal (HF) and vertical (VF) flows (Vymazal 2011b). Higher removal rates were found in 524 
systems with sub-surface flow (horizontal) CWs to surface flow CWs (Imfeld et al., 2009; Berglund 525 
et al., 2014; Bhatia and Goyal 2014; Li et al., 2014b; Díaz‐Cruz and Barceló 2015). Other important 526 
parameters are water depth, HRT, vegetation type, temperature (seasonality), and substrate (CWs 527 
filling) type (Verlicchi and Zambello 2014; Zhang et al., 2014). 528 
In the literature, various CWs applications for CEC removal are described, and details for the 529 
selected compounds are given in Table 5 and Table SM4, and described below. Current literature 530 
focuses on measuring influent and effluent concentrations of CEC to evaluate the overall removal 531 
performance, rather than detailed studies on the actual fate of target compounds or their removal 532 
pathways. CWs have shown the potential to remove CEC from urban/domestic wastewaters, 533 
including diclofenac, metformin, carbamazepine, triclosan, trimethoprim, clarithromycin, 534 
erythromycin, sulfamethoxazole, estrone, 17β-estradiol, 17α-ethynylestradiol, and benzotriazole (see 535 
Table 5 and Table SM4 for details and percent removal efficiency). Diclofenac is the most studied 536 
CEC, described in almost 70% of the published studies on CEC removal in CWs (see Table 5). Other 537 
well-studied compounds are the pharmaceuticals carbamazepine and triclosan and the antibiotics 538 
trimethoprim and sulfamethoxazole.  539 
In detail, many of the studied compounds showed removal up to 100%. Nevertheless, the removal 540 
percentage is dependent on the CWs operational parameters, e.g. surface flow or subsurface flow 541 
(either horizontal or vertical) as can be seen in Table SM4. For instance, benzotriazole and 542 
trimethoprim were more effectively removed in vertical subsurface flow CW that in a surface flow 543 
CW. Especially the vertical sub-surface flow CWs are known to promote biodegradation. The water 544 
flow affects the redox conditions which in turn affects removal mechanisms, resulting e.g. in a better 545 
removal of metformin under oxic conditions in a sub-surface flow CW. Other factors, such as plants 546 
presence, plants species and temperature (seasonal) can also determine compounds removal. For 547 
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instance, the removal of E1, E2 and EE2 increased in summer compared to winter. On the other 548 
hand, erythromycin and clarithromycin removals were favoured in the presence of plants, 549 
particularly in the presence of Iris tectorum. Triclosan removal was also favoured by a higher 550 
temperature and by the presence of the plant Phragmites australis. Details on these studies are given 551 
in Table SM4. 552 
Despite the high removal rates observed for the above-mentioned compounds, at least three 553 
compounds showed limited removal in CWs, due to their more recalcitrant nature. Diclofenac, 554 
carbamazepine and sulfamethoxazole were poorly removed in most studies, with only 1 or 2 studies 555 
showing higher removal. For example, a reported removal of carbamazepine in sub-surface 556 
horizontal flow CWs higher than 88% is remarkable (Garcia-Rodríguez et al., 2014), as this 557 
pharmaceutical is known to be poorly biodegradable. The mechanism of carbamazepine removal has 558 
not been fully elucidated, but Garcia-Rodríguez et al., (2014) describe a relation between the 559 
removal efficiency and residence time in the CW. The few parameters that are known to have a 560 
positive effect, e.g. vertical subsurface flow, higher temperature and plant presence, only slightly 561 
improved the removal of these three compounds. As a result, these 3 compounds are considered 562 
moderately removed by CWs indicating that CWs treatment should be combined with other 563 
wastewater treatments for an efficient removal of these compounds for wastewaters. 564 
Other CEC, such as the antibiotics enrofloxacin (veterinary application) and ciprofloxacin, have not 565 
been mentioned in studies of urban/domestic wastewater CWs treatment. However, studies with e.g. 566 
livestock wastewater show the potential of CWs for secondary treatment (Hsieh et al., 2015; Almeida 567 
et al., 2017).So far, removal of the majority of industrial chemicals (see Table 5), neonicotinoids, and 568 
selected pesticides in a CW has not been described. Of the neonicotinoids, 100% removal of 569 
imidacloprid in a CW has been reported, although spiked water was used instead of real wastewater. 570 
These results indicate that more research on CWs applicability to remove these compounds from 571 
wastewater is needed.  572 
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To conclude, CWs can be used for secondary treatment of wastewater containing selected CEC. 573 
There are several factors important when using a CW, such as the available area, CW design and 574 
operational conditions and the impact of seasonal conditions. Just like CAS systems, current CWs 575 
are not able to entirely eliminate CEC from wastewater. The efficiency of the processes occurring in 576 
CWs depends primarily on the operation mode, design, type of substrate and the presence and type of 577 
plants. The effectiveness of the processes in the CWs can be increased by the use of hybrid systems, 578 
which combine CWs of different design connected in series (Vymazal 2011b; Garcia-Rodríguez et 579 
al., 2014; Verlicchi and Zambello 2014; Zhang et al., 2014; Díaz‐Cruz and Barceló 2015). 580 
Combinations of CWs with other processes are also feasible, e.g. processes induced by sunlight 581 
(with/without photocatalysts) as the final stage of purification (Mahabali and Spanoghe 2013; Felis 582 
et al., 2016; He et al., 2016). 583 
 584 
  585 
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Table 5. Range of the removal efficiencies of selected CEC in different types of CWsa 586 
Category Removal 
efficiency (%) 
References 
Antibiotics   
Trimethoprim 0-100 (Hijosa-Valsero et al., 2011a; Dan et al., 2013; Du et al., 2014; Chen et 
al., 2016; Ávila et al., 2017)  
Erythromycin 0-92 (Hijosa-Valsero et al., 2011a; Ávila et al., 2014b; Du et al., 2014; Chen et 
al., 2016)  
Clarithromycin 11-98 (Hijosa-Valsero et al., 2011a; Chen et al., 2016; Vymazal et al., 2017) 
Azithromycin N.A.  
Sulfamethoxazole 0-75 (Hijosa-Valsero et al., 2011a; Dan et al., 2013; Du et al., 2014; Chen et 
al., 2016; Auvinen et al., 2017; Ávila et al., 2017) 
Enrofloxacin N.A.  
Ciprofloxacin N.A.  
Other pharmaceuticals/antimicrobials 
Diclofenac  0-75 (Matamoros and Bayona 2006; Matamoros et al., 2007; Matamoros et al., 
2009; Hijosa-Valsero et al., 2010b; Hijosa-Valsero et al., 2011a; Hijosa-
Valsero et al., 2011b; Hijosa-Valsero et al., 2012; Reyes-Contreras et al., 
2012; Ávila et al., 2013; Ávila et al., 2014a; Ávila et al., 2014b; Carranza-
Diaz et al., 2014; Du et al., 2014; Hijosa-Valsero et al., 2016; Auvinen et 
al., 2017; Vymazal et al., 2017) 
Metformin 99±1 (Auvinen et al., 2017) 
Carbamazepine 0-50 (Hijosa-Valsero et al., 2010b; Hijosa-Valsero et al., 2011a; Hijosa-
Valsero et al., 2011b; Reyes-Contreras et al., 2011; Camacho-Muñoz et 
al., 2012; Hijosa-Valsero et al., 2012; Reyes-Contreras et al., 2012; 
Carranza-Diaz et al., 2014; Du et al., 2014; Hijosa-Valsero et al., 2016; 
Auvinen et al., 2017; Ávila et al., 2017) 
Lamotrigine N.A.  
Triclosan 2-88 (Matamoros et al., 2007; Reyes-Contreras et al., 2011; Ávila et al., 2014b; 
Carranza-Diaz et al., 2014; Vymazal et al., 2017) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
N.A.  
Tris(2-chloroethyl) 
phosphate (TCEP) 
N.A.  
Tetrabromobisphenol A N.A.  
Hexabromocyclododecane 
(HBCD) 
N.A.  
Benzotriazole (BTA) 8-100 (Matamoros et al., 2010) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
N.A.  
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Perfluorobutanoic acid 
(PFBA) 
N.A.  
Perfluoropentanoic acid 
(PFPeA) 
N.A.  
Perfluorohexanoic acid 
(PFHxA) 
N.A.  
Estrogens 
Estrone (E1) 0-90 (Peterson and Lanning 2009; Qiang et al., 2013; Vymazal and Březinová 
2015; Dai et al., 2016) 
17-Estradiol (E2) 0-100 (Peterson and Lanning 2009; Qiang et al., 2013; Vymazal and Březinová 
2015; Dai et al., 2016) 
17-Ethynylestradiol 
(EE2) 
8-100 (Kumar et al., 2011; Qiang et al., 2013; Ávila et al., 2014b; Vymazal and 
Březinová 2015)  
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
N.A.  
Neonicotinoids 
Imidacloprid N.A.  
Thiacloprid N.A.  
Thiamethoxam N.A.  
Clothianidin N.A.  
Acetamiprid N.A.  
Pesticides 
Methiocarb N.A.  
Oxadiazon N.A.  
Triallate N.A.  
 587 
  588 
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4.5 Moving bed biofilm reactor  589 
Moving bed biofilm reactors (MBBRs) seem to be a promising alternative for the elimination of 590 
micropollutants. However, only few studies reported the application of the MBBR technology for 591 
CEC removal (Escola Casas et al., 2015a; Mazioti et al., 2015), and the studies based on real 592 
wastewater and full- to pilot-scale systems are missing. Therefore, lab-scale studies evaluating 593 
MBBR process as a secondary treatment for CEC removal from wastewater, which were based either 594 
on synthetic wastewater or hospital wastewater, are also considered. The contribution of biofilm 595 
communities (Torresi et al., 2017), its add-in value inside a hybrid MBBR system (Falas et al., 2013; 596 
Escola Casas et al., 2015b) or its contribution as a polishing treatment (Escola Casas et al., 2015b; 597 
Tang et al., 2017; Torresi et al., 2017) for CEC removal were also investigated. Details of these 598 
studies can be found in Table 6, Table SM5 and Table SM6. 599 
The performance of an MBBR system for the removal of pharmaceuticals from pre-treated hospital 600 
raw wastewater was evaluated by Escola Casas et al., (2015a). The system consisted of three 601 
identical reactors in series, with biomass concentrations of 3.1, 1.4, and 0.5 g/L respectively. The 602 
results showed that both high organic load (co-metabolism in the first reactor) and low organic load 603 
(more effective biofilm in the third reactor) acted for the overall removal of the pharmaceuticals. 604 
However, the comparison of the kinetic coefficient kbiol between the three reactors showed that four 605 
pharmaceuticals had higher kbiol in the third reactor (carbamazepine, clarithromycin, ciprofloxacin, 606 
and erythromycin) while diclofenac, sulfamethoxazole, and trimethoprim showed higher kbiol in the 607 
second one. Escola Casas et al., (2015a) paved the way for the development of MBBR reactors with 608 
higher concentration of efficient biomass for the removal of recalcitrant pharmaceuticals. 609 
Mazioti et al., (2015) compared degradation of benzotriazole in CAS with a sludge return (HRT 26.4 610 
± 2.4 h), MBBR at high organic load rate (OLR) (0.25 ± 0.16 kg m-3 d-1, HRT 10.8 ± 1.2 h), and 611 
MBBR at low OLR (0.6 ± 0.4 kg m-3 d-1, HRT 26.4 ± 2.4 h). Results showed similar removal 612 
efficiencies for the MBBR and CAS system at low OLR and worse results at high OLR. Specific 613 
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removal (µg g-1 d-1) tripled between the first reactor at high OLR and the first reactor at low OLR 614 
(11.9 ± 1.3 µg g-1 d-1) or the second bioreactor at high OLR (11.0 ± 5.3 µg g-1 d-1). As co-metabolism 615 
(COD and NH4) showed nearly no differences for benzotriazole removal, this difference should be in 616 
relation with biomass specification even no bacterial communities’ analysis was performed.  617 
In general, the efficiency of biological process is linked with physicochemical characteristics of the 618 
compound (kbiol, kd) and process parameters (temperature, HRT, SRT, pH, redox conditions). As 619 
MBBR is a biological process, the main removal mechanism is biodegradation which is quantified 620 
by the kbiol constant (L h-1g-1). SRT, OLR, and nitrification rate are higher in MBBR and have a 621 
positive impact on CEC removal (Oulton et al., 2010).  622 
These studies showed that both co-metabolism and balanced bacterial diversity could enhance CEC 623 
removal to some extent. The application of MBBR is not restricted to secondary biological treatment 624 
but may also have a successful future in polishing treatment. A comprehensive bibliographic review 625 
has been done on use of bacterial supports for the CEC removal and is summarized in Table 6, Table 626 
SM5 and Table SM6.  627 
  628 
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Table 6. Range of the removal efficiencies of the selected CEC in MBBRs  629 
Category Removal 
efficiency (%) 
References 
Antibiotics   
Trimethoprim 2-96  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Erythromycin 16-35  (Escola Casas et al., 2015a; Escola Casas et al., 2015b) 
Clarithromycin 47-61  (Escola Casas et al., 2015a; Escola Casas et al., 2015b) 
Azithromycin BDL-34  (Escola Casas et al., 2015a; Escola Casas et al., 2015b) 
Sulfamethoxazole (-28)-28  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Enrofloxacin (-36)-21  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Ciprofloxacin 2-96  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Other pharmaceuticals/antimicrobials 
Diclofenac  
25-100 
 
(Falas et al., 2013; Zupanc et al., 2013; Luo et al., 2014; Luo et al., 2015; 
Tang et al., 2017) 
Metformin N.A.  
Carbamazepine 
0-75 
(Falas et al., 2013; Zupanc et al., 2013; Luo et al., 2014; Escola Casas et 
al., 2015a; Escola Casas et al., 2015b; Luo et al., 2015; Tang et al., 2017) 
Lamotrigine N.A.  
Triclosan 80-92 (Luo et al., 2014; Luo et al., 2015) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
N.A.  
Tris(2-chloroethyl) 
phosphate (TCEP) 
N.A.  
Tetrabromobisphenol A N.A.  
Hexabromocyclododecane 
(HBCD) 
N.A.  
Benzotriazole (BTA) 43-76  (Mazioti et al., 2015) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
N.A.  
Perfluorobutanoic acid 
(PFBA) 
N.A.  
Perfluoropentanoic acid 
(PFPeA) 
N.A.  
Perfluorohexanoic acid 
(PFHxA) 
N.A.  
Estrogens 
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Estrone (E1) 65-95 (Luo et al., 2014; Luo et al., 2015; Amin et al., 2018) 
17-Estradiol (E2) 95-100 (Luo et al., 2014; Luo et al., 2015; Amin et al., 2018) 
17-Ethynylestradiol 
(EE2) 
90-98 (Luo et al., 2014; Luo et al., 2015; Amin et al., 2018) 
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
N.A.  
Neonicotinoids 
Imidacloprid N.A.  
Thiacloprid N.A.  
Thiamethoxam N.A.  
Clothianidin N.A.  
Acetamiprid N.A.  
Pesticides 
Methiocarb N.A.  
Oxadiazon N.A.  
Triallate N.A.  
  630 
  631 
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5. Effect of secondary treatments on microbial CEC fate  632 
Although antibiotic resistance and antibiotic residues may occur together in the environment, 633 
antibiotic resistance is not a direct consequence of chemical environmental contamination (Michael 634 
et al., 2013; Varela et al., 2014). Instead, ARB&ARGs are emitted from human and animal sources, 635 
also irrespective of the occurrence of antibiotics, and have the capacity to survive or self-replicate in 636 
the environment. These arguments place ARB&ARGs among the broad group of CEC (Pruden et al. 637 
2006; Berendonk et al. 2015). Given the current state of the art and the knowledge gaps concerning 638 
the effect of secondary treatment on antibiotic resistance, this section discusses why urban 639 
wastewater treatment plants are reservoirs of ARB&ARGs (Berendonk et al., 2015; Manaia et al., 640 
2016) and why control strategies are so difficult to devise and implement. WWTPs collect most of 641 
the pharmaceutical compounds, including antibiotic residues which are increasingly used in the 642 
modern medicine and poorly metabolized in the human body (Segura et al., 2009; Segura et al., 643 
2011; Michael et al., 2013). Unfortunately, antibiotic residues do not come alone. They are mingled 644 
with a wide diversity of human commensal and pathogenic bacteria, many of which harbour ARGs, 645 
acquired in a bacterial struggle for survival, while being able to persist and spread in the environment 646 
(Manaia et al., 2016). ARGs may be located on chromosomes or on plasmids, making the horizontal 647 
transfer of genes among neighbouring cells a possibility. Resistance genes encode different types of 648 
defence mechanisms that alone or in combination with other genetic determinants, may increase the 649 
capacity of bacteria to survive adverse conditions (Yomoda et. al., 2003; Kim et al., 2014). 650 
Wastewater secondary treatment systems have the potential to offer ideal conditions for bacteria to 651 
spread their genes, in particular ARGs, and hence they can be associated with antibiotic resistance 652 
dissemination (Rizzo et al., 2013, Bouki et al., 2013). The wealth of nutrients and cell-to-cell 653 
interactions, aided by the presence of antibiotic residues and, eventually, other selectors, are believed 654 
to enhance the chances of survival or even proliferation of ARB (Berendonk et al., 2015; Bengtsson-655 
Pvaalme and Larsson, 2016). 656 
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The need of elucidating the potential impact of WWTPs on the dissemination of ARB&ARGs has 657 
been urged by the accumulation of evidences that the use of reclaimed water used for irrigation may 658 
contribute to the transmission of ARB and other water-borne bacteria through different 659 
environmental compartments. Potential microbiological risks associated with water reuse in 660 
irrigation cannot be neglected (Pachepsky et al., 2012; Al-Jassim et al., 2015) and this review aimed 661 
at assessing what is known regarding ARB&ARGs removal by full-scale WWTP systems operated 662 
with different secondary treatment technologies. 663 
Recent studies on this topic that share common overall experimental approaches are reviewed in this 664 
paper (Table 7). Given the relevance of the disinfection effects on the fate of ARB&ARGs and the 665 
difficulty in identifying the role of the secondary treatment units from the available literature, some 666 
data reported in the Table 7 includes also the disinfection step. A few aspects that can explain the 667 
variation in the data presented are worth mentioning (Table 7). First, diverse methodologies are used 668 
for the screening of genes in total DNA extracts or cultivation methods, a disparity that is enhanced 669 
by a wide array of variables that may influence the results. For culture-based methods, the results 670 
will be strongly influenced by the choice of the culture medium or the imposition of some selective 671 
pressures. For culture-independent methods, the DNA extraction process, the primers used for PCR-672 
based gene search or the technique and conditions used for metagenome analyses as well as the 673 
database and analytical pipeline used, are enough to influence the results. Second, there is a lack of 674 
information on the external conditions during the full-scale conventional treatment, not only those 675 
referring to operational settings, but also climate conditions and numerous quality parameters. Third, 676 
the sampling scheme is different among studies and microbial targets analysed. In spite of such 677 
potential confounding variables, we can conclude that full-scale CAS plants have a limited capacity 678 
to reduce antibiotic resistance to negligible levels. In the next section, we will discuss the impact of 679 
the WWTP processes on: i) culturable total and ARB, ii) multi-drug resistance phenotypes, iii) ARGs 680 
and iv) metagenomics insights of antibiotic resistance. 681 
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5.1 Fate of culturable antibiotic-resistant bacteria 682 
The reduction in the number of total and ARB has been examined in various studies, in the influent 683 
and secondary effluent of WWTP as a method to infer the efficiency of wastewater treatment to 684 
remove antibiotic resistance. This is achieved with the use of bacterial cultivation and enumeration 685 
methods, in selective media supplemented or not with antibiotics. This approach can be used to 686 
assess the effectiveness of the WWTP process as for instance is reported by Zanotto et al., (2016). 687 
These authors showed that a CAS process could reduce the ampicillin and chloramphenicol-resistant 688 
coliforms and Escherichia coli by 2 log units. However, the biological treatment did not reduce the 689 
percentage of ARB among total bacteria (maintenance of prevalence values). It has been shown in 690 
this study that the disinfection step with peracetic acid was important in the reduction of ampicillin-691 
resistant E. coli, to densities below 10 CFU/100 mL. In contrast, in another study by Mao et al., 692 
(2015), it was observed that bacteria harbouring ARGs persisted throughout all treatment stages, 693 
surviving better after chlorination than total bacteria. Su et al., (2014) observed that even though total 694 
culturable bacteria and E. coli decreased after the WWTP process (2.3-3.3 log unit reduction), the 695 
quinolone- and ampicillin-resistant bacteria prevalence was not significantly reduced (from 55% in 696 
the influent to 61% in the effluent). Sidrach-Cardona and Bécares (2013) have shown removal of 90-697 
99% ARB from urban wastewater in CWs. This study showed that CWs design can affect the system 698 
performance, with planted sub-surface flow CWs being more efficient for this type of biological 699 
pollutants. Processes such as filtration, adsorption, aggregation, and metabolic activity of biofilm 700 
microorganisms and macrophytes are responsible for bacterial removal in CWs (García et al., 2008; 701 
Wu et al., 2016). It is not clear if plants have a direct effect on bacterial removal, as the presence of 702 
plants can indirectly increase removal through conductivity modification, gas transport and 703 
enhancement of biofilm development, adsorption, aggregation and filtration (García et al., 2008).  704 
The above suggest that the tertiary treatment is important in the removal of total bacteria, but it is not 705 
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always effective in removing ARB, thus leading to their persistence in the disinfected effluent, with 706 
possible contamination of the receiving environment.  707 
5.2 Multi-drug resistance phenotypes 708 
Multidrug-resistant (MDR) bacteria have been defined as those that have acquired non-susceptibility 709 
to at least one agent belonging to three or more antimicrobial categories (ECDC/EMEA, 2009). It 710 
was shown in several studies that MDR phenotypes occur in final effluent samples, evidencing that, 711 
as for many other bacteria, also MDR bacteria can survive treatment. Among the studies included in 712 
this review, there were MDR-positive isolates to the following antibiotics, among others: 713 
ciprofloxacin, trimethoprim and sulfamethoxazole/trimethoprim (Al-Jassim et al., 2015; Zhang et al., 714 
2015b; Lopes et al., 2016; Osinska et al., 2017). The same pattern of MDR E. coli isolates was found 715 
by Osinska et al., (2017) and Lopes et al., (2016) in the wastewater effluent analysed, showing 716 
prevalence values above 30%. The prevalence of MDR E. coli isolates reported by Blaak et al., 717 
(2015) was lower, but still represented 20% of the total number of isolates in effluent wastewater. 718 
Kotlarska et al., (2015) also reported MDR E. coli in wastewater effluent in two WWTPs (2.4 (0.1–719 
6.1) × 105 and 2.1 (0.8–3.1) × 105 CFUs per 100 mL). Zhang et al., (2015b) selected 200 720 
heterotrophic bacteria from three WWTPs (influent and effluent), seasonally. They reported MDR 721 
isolates ranging from 5 to 64%.  From these studies it is not possible to draw a general overview or 722 
define a trend. Apparently, more studies targeting MDR phenotype prevalence in wastewater 723 
effluents may be needed, preferentially targeting other bacteria besides E. coli. Another limitation is 724 
the use of ambiguous and not always correct definitions of MDR that are reported in the scientific 725 
literature, which may launch several misinterpretations of the meaning and impact of MDR in urban 726 
wastewater effluents.  727 
 728 
5.3 Fate of antibiotic resistance genes  729 
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The quantitative PCR (qPCR) of specific ARGs has brought a new breath to the assessment of 730 
wastewater treatment efficiency regarding the removal of antibiotic resistance genes. Rafraf et al., 731 
(2016) observed the presence of various ARGs including the integrase gene except blaCTX-M in the 732 
influent and effluent samples of five WWTPs employing biological processes (CAS, CAS-UV, 733 
aerated lagoon). The quantification of the examined ARGs showed that there was no difference in 734 
their abundance before and after the treatment which is also in agreement with Xu et al., (2015), once 735 
more highlighting the tolerance of ARB and their associated genes to the applied WWTP treatments. 736 
This is supported by the study of Al-Jassim et al., (2015), where it was observed that tetO, tetQ, 737 
tetW, tetH, tetZ were also present in the post-CAS chlorinated treated effluent. Wen et al., (2016) 738 
observed that the biological treatment had an important role in the removal of ARGs followed by UV 739 
disinfection, although high concentrations of ARGs were found in the treated effluents. Mao et al., 740 
(2015) observed a 90% reduction in ARGs from influent to effluent in CAS. However, even after 741 
chlorination, the remaining ARGs were still in high levels, and tetA, tetB, tetE, tetG, tetH, tetS, tetT, 742 
tetX, sul1, sul2, qnrB and ermC were discharged through the dewatered sludge and plant effluent at 743 
higher rates than influent values. The latter finding is supported by the study of Alexander et al., 744 
(2015), where the abundance of various ARGs increased after conventional WWTP process, 745 
resulting in the surface water receiving a high abundance of various ARGs. Laht et al., (2014) 746 
demonstrated a decrease by several orders of magnitude in raw 16S rRNA and ARGs gene copy 747 
numbers (tetC, tetM, sul1, sul2, blaCTX-M-32, blaSHV-34, blaOXA-58) in the effluent compared to the 748 
influent, in three CAS WWTPs. In the same study, when the ARGs abundance was normalised per 749 
16S rRNA, it was shown that when relative abundances were compared, there was a statistically 750 
significant difference (p<0.01) between influent and effluent samples, in only four cases, among the 751 
three examined WWTPs. This is a finding which is in agreement with a study on CAS by Bengtsson-752 
Palme et al., (2016). CWs have shown the removal potential of both antibiotics and antibiotic 753 
resistance genes in a few studies as reviewed by Sharma et al., (2016), which can ultimately affect 754 
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the amount of antibiotic resistance bacteria in CWs effluents. In these studies, both domestic/urban 755 
and livestock wastewaters have been tested. For domestic/urban wastewaters, CWs can remove 756 
significant amounts of antibiotic resistance genes (45-99 %) belonging, for instance, to tetracycline, 757 
fluoroquinolone and sulfonamides antibiotic classes (Liu et al., 2013; Nolvak et al., 2013; Chen et 758 
al., 2015; Huang et al., 2015; Chen et al., 2016; Huang et al., 2017).  759 
However, most of the papers present the removal results after a combined treatment process 760 
consisting of biological treatment and disinfection, and do not provide data on the actual biological 761 
process removal effectiveness. Therefore, it is not possible to clearly distinguish the effects of the 762 
biological treatment on the ARGs. 763 
5.4 Antibiotic resistance through the metagenomics lens 764 
Metagenomics approaches applied to resistome and bacterial community analyses have come into the 765 
spotlight in the last few years, due to the rapid technological development and reduction in the 766 
potential cost of such equipment. As a result, more studies are arising which perform in-depth 767 
analyses of the resistome and wastewater bacterial communities before and after WWTP processes. 768 
Christgen et al., (2015) explored five wastewater treatment options, such as: i) a completely mixed 769 
aerobic reactor (AER1), ii) an up-flow anaerobic sludge blanket reactor (UASB), iii) an anaerobic 770 
hybrid reactor (AHR), and iv-v) two anaerobic−aerobic sequence (AAS) bioreactors following 771 
UASB and AHR reactors, respectively. The analysis of the relative abundance of ARGs (abundance 772 
of ARG sequences reads the total reads number) showed that the AAS and aerobic treatment were 773 
able to remove a higher number of ARGs, among the total number of reads, such as 774 
aminoglycosides, tetracycline and β-lactam resistance genes compared to UASB and AHR, 775 
indicating the higher capacity of the combined aerobic system for ARGs removal, compared to the 776 
anaerobic processes. However, the relative abundance of sulfonamide and chloramphenicol 777 
resistance genes was unaffected by AAS. In another study (Yang et al., 2014), identified 271 778 
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subtypes of ARGs belonging to 18 classes. The highest abundance of ARGs among the total number 779 
of reads was observed in the influent of the WWTP, while 78 ARGs persisted throughout the 780 
treatment, among the total number of ARGs reads. Finally, significant statistical correlation between 781 
specific bacterial genera which include opportunistic pathogens, and ARGs distribution, was 782 
observed, suggesting their contribution as carriers of ARGs. 783 
  784 
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 786 
Table 7. Most recent studies examining the fate of ARB&ARGs in full-scale WWTPs operated with different processes and technologies  787 
Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) 
Biological target/experimental 
approach/chemical analyses 
Study findings 
Poland 
 
(Osinska et al., 2017) 
 
 
 
Conventional 
Activated Sludge 
(CAS) 
Compare antibiotic resistance and 
virulence before and after CAS 
treatment 
   
Isolates: E. coli resistant to amoxicillin, tetracycline 
or ciprofloxacin 
Approach: Isolation on mFC, genotyping (ERIC-
PCR), antibiograms (3 antibiotics), gene detection 
(PCR) 
Reduction of the counts of beta-lactam, tetracycline and fluoroquinolone-resistant E. coli 
after treatment 
Multi-drug resistance observed in 38% of the 317 isolates analysed 
Most common antibiotic resistance genes: blaTEM and blaOXA and tetA, tetB and tetK  
Most common virulence genes: bfpA, ST and eae  
Brazil 
 
(Conte et al., 2017) 
 
 
 
 
CAS 
Survey of beta-lactam and 
quinolone resistant bacteria after 
CAS treatment 
Isolates: E. coli, Klebsiella pneumoniae and 
K.  oxytoca resistant to quinolones  
Approach: Isolation on MacConkey, genotyping 
(ERIC-PCR), antibiograms (9 antibiotics) and MICs 
(8 antibiotics), gene detection (PCR) 
Antibiotics: Ciprofloxacin 
Cephalosporin and quinolone resistance found in 34.4% of E. coli and 27.3% of K. 
pneumoniae 
Carbapenem resistance found in 5.4% of K. pneumoniae and K. oxytoca 
ESBL-producing isolates found in raw and treated water samples  
Ciprofloxacin residues were absent only in upstream river water 
China 
 
(Ben et al., 2017) 
1) Anaerobic/anoxi
c/oxic (A2/O)-
Membrane 
Bioreactor 
(MBR) 
2) Oxidation ditch-
coagulation/sedi
mentation 
3) Anoxic/oxic 
(A/O)-MBR 
4) A2/O-
ultrafiltration 
(UF) 
5) A/O-biofilter-UF 
6) A/O 
7) Oxidation ditch-
Rotary fibre disk 
filtration (RFDF) 
8) A2/O- RFDF 
9) A2/O/coagulation
/sedimentation-
RFDF 
10) A2/O-
coagulation/sedi
mentation-RFDF 
Assess possible correlations 
between antibiotic resistance and 
sulfonamides (SA) or 
tetracyclines (TC) in ten WWTPs 
with different treatment types, all 
of them including disinfection   
Isolates: Heterotrophic bacteria, resistant to 
tetracycline and sulfamethoxazole 
Total community DNA 
Approach: Isolation on LA, gene quantification 
(qPCR) 
Antibiotics: Sulfonamides, tetracyclines 
 
ARGs detected after treatment in all 10 WWTP, with sulfonamide resistance being the most 
abundant type of resistance 
Total SA and TC concentrations were not significantly correlated with the corresponding 
ARB&ARGs 
Positive correlation between ARGs and intI1 
The statistically significant decrease of ARGs abundance evidences the importance of 
disinfection for antibiotic resistance control 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) 
Biological target/experimental 
approach/chemical analyses 
Study findings 
 
Brazil 
 
(Lopes et al., 2016) 
Biological aerated 
filter system 
(RALF) 
Assess the occurrence of 
thermotolerant coliforms and E. 
coli resistant to various 
antimicrobials in an WWTP 
Isolates: thermotolerant coliforms, antibiotic-resistant 
E. coli   
Approach: Isolation on non-selective medium and 
antimicrobial susceptibility testing 
Antibiotics: norfloxacin, ciprofloxacin, cephalothin, 
gentamycin, streptomycin, imipenem, cefaclor, 
ampicillin, cefoxitin, tetracycline, amoxicillin and 
chloramphenicol 
 
There were E. coli isolates resistant to cephalothin, streptomycin, tetracycline and 
amoxicillin; 
A higher prevalence of resistant isolates was observed in the WWTP effluent and 
downstream of the WWTP. 
Tunisia 
 
(Rafraf et al., 2016) 
 
 
1) CAS 
2) CAS-UV 
3) Aerated Lagoons 
Assess the efficiency of 
wastewater treatment on 
antibiotic resistance removal in 
five WWTP (four with CAS one 
of which has CAS-UV, and one 
with aerated lagoons as the 
secondary process) 
Total community DNA  
Approach: gene quantification (qPCR) 
 
The gene intI1 and all ARGs, except blaCTX-M, were detected in influent and effluent samples 
in all WWTPs tested with relative ARGs abundance being similar before and after treatment 
The abundance of blaCTX-M, blaTEM, and qnrS genes was higher in the effluent of the WWTP 
that receives untreated hospital effluents 
China 
 
(Sun et al., 2016) 
 
 
 
A2/O -MBR 
Assess the overall distribution of 
ARGs by a common wastewater 
treatment process, the A/A/O-
MBR process, in different 
geographical locations 
Total community DNA 
Approach: GeoChip 4.0 using 2812 nucleotide 
probes of ARGs 
There was a large diversity of ARGs among the MBRs, with only around 40% of commonly 
detected ARGs worldwide being detected 
There were different dominant ARGs groups in each MBR, with the majority of ARGs being 
derived from Proteobacteria and Actinobacteria 
TN, TP and COD of influent and temperature and conductivity of MLSS were significantly 
correlated to the ARGs distribution in the different MBRs 
Finland 
 
(Karkman et al., 
2016) 
 
 
CAS-Biofilter 
 
 
Assess seasonal variations of 
transposase and ARGs abundance 
in an WWTP utilizing CAS and 
biofilters as tertiary treatment 
Total community DNA  
Approach: gene detection (qPCR array) 
All transposases and 66% of all ARGs assayed were detected in the effluent and nine ARGs 
were enriched in the effluent compared to the influent  
WWTP with tertiary treatment system analyzed substantially decreased the gene abundance 
and richness (>99% reduction) 
Sweden 
 
(Bengtsson-Palme et 
al., 2016) 
 
 
 
 
CAS 
Assess the occurrence of genes 
against antibiotics, biocides and 
metals and their co-selection 
potential in WWTP utilizing the 
CAS process 
 
Total community DNA  
Approach: Metagenomics-Resistome 
Antibiotics: Macrolides, fluoroquinolones, 
tetracyclines, sulfonamides 
Other: Metals, biocides 
No consistent enrichment of ARGs to any particular antibiotic class, for neither biocide nor 
metal resistance genes 
WWTP greatly reduced the number of resistance genes per volume of water, their relative 
abundance per bacterial 16S rRNA was only moderately decreased  
A few resistance genes, including the carbapenemase gene blaOXA-48, were enriched in the 
treatment process 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) 
Biological target/experimental 
approach/chemical analyses 
Study findings 
Italy  
 
(Zanotto et al., 2016) 
 
 
 
CAS-Peracetic acid  
Assess antibiotic resistance 
dynamics over different treatment 
stages (CAS and peracetic acid 
disinfection)  
Isolates: Total coliforms, E. coli resistant to 
ampicillin and chloramphenicol 
Approach: Isolation on chromogenic agar, gene 
detection (PCR) 
Biological process effective in the reduction of the ampicillin and chloramphenicol-resistant 
total coliforms and E. coli by about 2-log units 
No significant decrease of the percentage of ARB through the biological treatment 
Disinfection significantly reduced the ampicillin-resistant E. coli  
China 
 
(Wen et al., 2016) 
1) A2/O 
2) A/O 
3) Cyclic activated 
sludge system 
(CASS) 
4) CASS 
Assess the distribution and 
removal efficiency of ARGs in 
four WWTPs with different 
treatment processes 
Total community DNA  
Approach: gene quantification (qPCR) 
Of all treatment steps, biological treatment played the most important role in ARGs removal, 
followed by UV disinfection  
ARGs were observed in all WWTP effluents after biological treatment process and their 
abundance was still high in the final effluent  
China 
 
(Li et al., 2016) 
1) A2/O 
2) Triple 
oxidation ditch 
Assess antibiotic resistance 
removal in two WWTP with 
different treatment types, 
including UV disinfection 
 
Isolates: Heterotrophic bacteria resistant to 
tetracycline or/and sulfamethoxazole  
Total community DNA 
Approach: Isolation on R2A, gene quantification 
(qPCR) 
Antibiotics: Sulfonamides, tetracyclines, 
trimethoprim 
 
The ARGs were detected in both WWTP effluents 
Biological treatment played the most important role on ARGs and antibiotics removal, and 
physical processes on ARB removal 
UV disinfection did not significantly enhance the removal efficiency 
High concentrations of antibiotics and abundance of ARGs and ARB were detected in the 
excess sludge samples 
China 
 
(Mao et al., 2015) 
 
 
 
 
 
 
CAS--Chlorination 
Assess the removal efficiency of 
ARGs, ARB and antimicrobial 
drugs, in two WWTP utilising 
CAS and chlorine disinfection 
Isolates: Heterotrophic bacteria resistant to 
sulfonamides, tetracyclines, ciprofloxacin and 
erythromycin 
Total community DNA 
Approach: Isolation on nutrient agar, gene detection 
(PCR) and quantification (qPCR) 
Antibiotics: Sulfonamides, trimethoprim, 
tetracyclines, β-lactams, fluoroquinolones, macrolides 
Heavy metals: As, Cd, Cr, Cu, Ni, Pb, Zn 
Bacteria harbouring ARGs persisted through all treatment units, surviving better to 
disinfection by chlorination than total bacteria 
The abundance of ARGs was reduced from the raw influent to the effluent (~90%), although 
high levels of ARGs levels were found in WWTP effluent samples 
The ARGs tetA, tetB, tetE, tetG, tetH, tetS, tetT, tetX, sul1, sul2, qnrB, ermC were 
discharged through the dewatered sludge and plant effluent at higher rates than influent 
values 
 
USA 
 
(Naquin et al., 2015) 
 
 
 
 
CAS-UV  
Assess the presence of ARGs in a 
small town WWTP utilizing CAS 
followed by UV disinfection  
Isolates: Total bacteria 
Total community DNA 
Approach: Isolates on TSA, antibiograms, gene 
detection (PCR), Genetic transformation assay 
(mecA) 
ARGs were present in both raw and treated wastewater during all the sampling periods  
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) 
Biological target/experimental 
approach/chemical analyses 
Study findings 
Saudi Arabia  
 
(Al-Jassim et al., 
2015) 
 
 
 
 
 
CAS-chlorination 
Assess the efficiency of removal 
of microbial contaminants in a 
WWTP utilizing CAS and 
chlorine disinfection 
Isolates: Total heterotrophic bacteria, total and faecal 
coliforms 
Total community DNA  
Approach: Isolation on nutrient agar, sulfate and 
brilliant green bile lactose and EC, antibiograms (8 
antibiotics), bacterial community analysis, gene 
quantification (qPCR) 
Antibiotics: ampicillin, kanamycin, erythromycin, 
tetracycline, ceftazidime, ciprofloxacin, 
chloramphenicol, meropenem  
16S rRNA gene-based community analysis showed that genera associated with opportunistic 
pathogens (e.g. Acinetobacter, Aeromonas, Arcobacter, Legionella, Mycobacterium, 
Neisseria, Pseudomonas and Streptococcus), were detected in the influent and some were 
found in chlorinated effluent 
The ARGs tetO, tetQ, tetW, tetH, tetZ were also present in the chlorinated effluent 
The proportion of bacterial isolates resistant to 6 types of antibiotics increased from 3.8% in 
the influent to 6.9% in the chlorinated effluent 
6.8% of isolates from influent were resistant to meropenem and 24% of the isolates were 
resistant in the chlorinated effluent 
25% of the isolates in the influent and 28% of isolates in the effluent were resistant to at least 
5 antibiotics  
 
United Kingdom  
 
(Christgen et al., 
2015)  
 
1. Upflow 
anaerobic sludge 
blanket reactor 
(UASB)2. 
Anaerobic hybrid 
reactor (AHR)3. 
Mixed aerobic 
reactor (AER1)  
4. and 5. Anaerobic 
aerobic sequence 
bioreactor (AAS) 
 
Assess ARGs removal in five 
different domestic wastewater 
treatment options 
Total community DNA  
Approach: Metagenomics-Resistome  
The AAS and aerobic treatment achieved a higher removal of certain ARGs (aminoglycoside, 
tetracycline, β-lactam resistance genes) compared to UASB and AHR, indicating the higher 
capacity of the combined system to remove ARGs compared to each process alone  
Sulfonamide and chloramphenicol resistance genes were unaffected by the AAS treatment 
while multi-drug resistance increased from influent to effluent 
Metagenomic data suggested that aerobic processes may be generally better than anaerobic 
processes for reducing ARGs 
Germany 
 
(Alexander et al., 
2015) 
Nitrification-
denitrification-
phosphorus 
elimination 
 
 
Detect and quantify genes and 
gene carriers of clinical 
significance; 
Assess the dissemination of 
ARGs and opportunistic bacteria 
in natural populations; 
Identify and monitor critical 
water systems and potential 
microbiological risks for human 
health 
Total community DNA 
Approach: Gene quantification (qPCR), 
quantification of antibiotic residues (LC-MS) 
Antibiotics: (Dehy-)erytromycin, Acetyl-
sulfamethoxazole, chloramphenicol, chlortetracycline, 
clarithromycin, doxicycline, erythromycin, 
metronidazole, oxytetracycline, roxithromycin, 
sulfadiazine, sulfadimidine, sulfamerazine, 
trimethoprim 
The removal capacities were up to 99% for some WWTPs tested, but not in all investigated 
bacteria; 
The abundance of most ARGs increased in the bacterial population after conventional 
wastewater treatment. As a consequence, downstream surface water and also some 
groundwater compartments displayed high abundances of all four ARGs 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) 
Biological target/experimental 
approach/chemical analyses 
Study findings 
China 
 
(Xu et al., 2015) 
 
 
 
A/O  
Assess the abundance and 
distribution of antibiotics and 
ARGs in a WWTP utilizing 
anaerobic/anoxic process and in 
its effluent-receiving river. 
Total community DNA 
Approach: gene quantification (qPCR)  
Antibiotics: Tetracyclines, sulfonamides, 
fluoroquinolones 
Concentration of tetracyclines, sulfonamides and quinolones decreased after treatment 
ARGs abundance did not vary over the different treatment stages 
Sulfonamide resistance genes were present at relatively high concentrations in all samples 
 
China  
 
(Zhang et al., 2015b) 
 
 
 
 
CAS 
Assess the antibiotic-resistance 
phenotypes in three WWTP 
utilizing CAS process.  
Isolates: Heterotrophic bacteria and total coliforms 
Total community DNA 
Approach: Isolation on R2A and MacConkey, 
antibiograms (12 antibiotics), gene quantification 
(qPCR) 
The proportion of bacterial isolates resistant to more than 9 antibiotics was lower in effluent 
isolates than in the influent 
Gram-negative bacteria dominated in influent and Gram-positive in effluent 
The ARGs examined had higher prevalence in ARB from the influent than in the effluent, 
except for sulA and blaCTX 
The abundance of ARGs in activated sludge from two of the three plants were higher in 
aerobic compartments than in anoxic ones 
Poland 
 
(Kotlarska et al., 
2015) 
1) A2/O 
2) Primary and 
secondary 
anoxic 
treatment 
Assess the antibiotic resistance 
profiles of E. coli isolated from 
two WWTP, their marine outfalls 
and from a major tributary of the 
Baltic Sea, in order to evaluate 
the role of the studied wastewater 
effluents and tributaries in the 
dissemination of integrons and 
ARGs. 
Isolates: E. coli  
Total community DNA 
Approach: Isolation on mFC agar, antimicrobial 
susceptibility tests, gene detection (PCR), sequencing 
of gene cassette arrays 
  
Ampicillin-resistant E. coli were the most frequently observed bacteria (<32%)  
32% and 3.05% of the isolates were positive for class 1 and 2 integrons, respectively 
The presence of integrons was associated with increased frequency of resistance to 
fluoroquinolones, trimethoprim/sulfamethoxazole, amoxicillin/clavulanate, 
piperacillin/tazobactam and MDR-resistance phenotype.  
The most predominant gene cassette arrays were dfrA1-aadA1, dfrA17-aadA5 and aadA1 
China 
 
(Du et al., 2015) 
 
 
 
A2/O-MBR  
Assess the variation of ARGs 
throughout a A2/O-MBR 
wastewater treatment process  
Total community DNA  
Approach: Gene quantification (qPCR) 
ARGs concentrations decreased in the anaerobic and anoxic effluent but increased in the 
aerobic effluent and sharply declined in MBR effluent 
The reduction in tetW, intI1 and sul1 was positively correlated with the variation of the 16S 
rRNA gene abundance  
ARGs concentrations reduced in the effluent samples as: sul1>intI1>tetX>tetG>tetW 
All ARGs concentrations were higher in spring compared to other seasons 
Spain 
 
(Rodriguez-Mozaz et 
al., 2015) 
 
 
 
CAS 
Assess the variation of antibiotics 
concentration and ARGs 
abundance in urban and hospital 
effluent from a WWTP utilizing 
CAS treatment 
Total community DNA 
Approach: Gene quantification (qPCR) 
Antibiotics: 62 antibiotics 
ARGs copy numbers of blaTEM, qnrS, ermB and sul1 were highest in hospital effluent and 
WWTP influent 
The copy number of ARGs decreased significantly in WWTP effluents but this reduction was 
not uniform across ARGs 
Prevalence of ermB and tetW decreased after WWTP treatment but blaTEM, qnrS and sul1 
prevalence increased 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) 
Biological target/experimental 
approach/chemical analyses 
Study findings 
Estonia and Finland 
 
(Laht et al., 2014) 
 
 
 
 
CAS-Secondary 
sedimentation 
 
Assess the role of three WWTP 
utilizing CAS followed by 
tertiary disinfection in the 
distribution of ARGs 
Total community DNA  
Approach: Gene quantification (qPCR) 
sul1, sul2, and tetM were detected in all samples while statistically significant differences 
between the influent and effluent were detected in only four cases 
The purification process caused no significant change in the relative abundance of ARGs, 
while the raw abundances fell by several orders of magnitude  
Standard water quality variables (BOD7, TP and TP, etc.) were weakly related or unrelated to 
the relative abundance of ARGs 
China 
 
(Yang et al., 2014)  
 
 
 
 
CAS Study the fate of ARGs in a 
WWTP utilizing CAS process 
Total community DNA  
Approach: Metagenomics-resistome 
271 ARGs subtypes belonging to 18 ARGs types were identified by the broad scanning of 
metagenomics analysis 
Influent had the highest ARGs abundance, followed by effluent, anaerobic digestion sludge 
and activated sludge 
78 ARGs subtypes persisted through the biological wastewater and sludge treatment process 
Significant correlation between specific bacterial genera, included potential pathogens, and 
the distribution of ARGs were observed  
China 
 
(Su et al., 2014) 
1) CAS -
chlorination 
2) CAS-oxidation 
ditch-UV 
disinfection 
Assess the effect of treatment on 
antibiotic resistance profiles in 
two WWTP utilizing: a) CAS 
followed by chlorine disinfection 
and b) oxidation ditch followed 
by UV disinfection 
 
Isolates: E. coli resistant to quinolones and β -
 lactams 
Approach: Isolates on nutrient agar, modified mTEC 
agar, antibiograms (12 antibiotics), gene detection 
(PCR) 
Antibiotics: ampicillin, piperacillin, cefazolin, 
ceftazidime, gentamycin, streptomycin, ciprofloxacin, 
levofloxacin, sulfamethoxazole/trimethoprim, 
trimethoprim, tetracycline, chloramphenicol 
98.4% of the isolates were resistant to the examined antibiotics and 90.6% were resistant to at 
least 3 antibiotics  
The number of the total cultivable bacteria and E. coli decreased after treatment  
Disinfection significantly reduced total bacteria but not ARB prevalence 
 
 
Portugal 
 
(Novo et al., 2013) 
 
 
 
 
CAS Assess the influence of abiotic 
factors on the levels of antibiotic 
resistance and bacterial structure 
community of the CAS-treated 
final effluent 
Isolates: Heterotrophic bacteria, enterobacteria and 
enterococci resistant to amoxicillin, tetracycline, 
ciprofloxacin and sulfamethoxazole 
Approach: Isolates on PCA, m-FC and m-Ent, 
genotyping (DGGE) 
Antibiotics: Tetracyclines, β-lactams, sulfonamides, 
fluoroquinolones 
Metals: Cd, Pb, Cr, As and and Hg 
Other: Triclosan 
The bacterial community was distinct in raw and in treated wastewater  
In Autumn, but not in Spring, amoxicillin and ciprofloxacin resistance prevalence increased 
significantly after wastewater treatment while temperature was positively correlated with the 
prevalence of sulfonamide resistant heterotrophs and enterobacteria in treated wastewater 
The concentration of tetracyclines, penicillins, sulfamides and quinolones and the abundance 
of antibiotic-resistant cultivable bacteria in the raw wastewater were positively correlated 
with the abundance of Epsilonproteobacteria in treated wastewater and negatively with 
Gamma-, Betaproteobacteria and Firmicutes 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) 
Biological target/experimental 
approach/chemical analyses 
Study findings 
China 
 
(Chen and Zhang 
2013) 
 
 
CAS, constructed 
wetlands (CWs), 
MBRs 
Assess the occurrence and 
removal of tet and sul resistance 
genes in 12 wastewater treatment 
systems with different treatment 
capacities and treatment 
processes including CAS, 
constructed wetlands and MBRs 
Total community DNA  
Approach: gene quantification (qPCR) 
Significant correlation between the gene copy numbers and wastewater receiving capacity 
were observed 
Statistical analysis revealed a positive correlation between the gene copy numbers of sul1 and 
intI1, whereas the gene numbers of tetM and sul1 were strongly correlated with 16S rRNA 
gene 
Spain 
 
(Sidrach-Cardona and 
Bécares 2013) 
Seven CWs of 
different types 
Evaluate removal of antibiotic 
resistant bacteria from urban 
wastewater by CWs with 
different design  
Isolates: E. coli, Coliforms and Enterococcus 
Approach: Isolates on coliform agar and SB agar 
Antibiotics: amoxicillin, azithromycin, 
amoxicillin+clavulanic acid, and doxycycline 
 
Removal efficiency 90 and 99%. 
Better results for Sub-surface flow CW, planted with Phragmites spp. 
Design parameters influencing their performance, those with sub-surface flow proving better 
than hydroponic, and planted better than unplanted 
Estónia 
 
(Nolvak et al., 2013) 
Pilot system 
consisted of a septic 
tank, followed by 
six parallel vertical 
subsurface flow 
mesocosms, a 
collection well, and 
21 parallel HSSF 
MCs 
Evaluate removal of antibiotic 
resistant genes from municipal 
wastewater by CWs with 
different design  
Total community DNA  
 
antibiotic resistance genes  
Antibiotic: tetracyclines, macrolides, sulfonamides, 
penicillins, and fluoroquinolones 
In general, the proportions of different ARGs decreased in mesocosm effluent bacterial 
communities (compared to the influent) during the treatment process – no percentages 
removal given 
Antibiotic resistance genes in the wetland media biofilm and in effluent were affected by 
system operation parameters, especially time and temperature 
China 
 
(Chen et al., 2015) 
 four surface and 
subsurface flow-
CWs, and a 
stabilization unit 
Evaluate removal of antibiotic 
resistant genes from rural 
domestic wastewater by CWs 
with different design 
Total community DNA  
antibiotics leucomycin, ofloxacin, lincomycin, and 
sulfamethazine 
>99% in total 
CW3 with 43.6%, followed by CW2 (27.5%), CW1 (11.9%), and CW4 (11.9%). The least 
contributing treatment unit was CW5, with a contributing rate of 2.6 % Sorption onto soil or 
medium and biodegradation are two main mechanisms for ARGs elimination in the ICW 
system. 
China 
(Chen et al., 2016) 
Six mesocosm-
scale CWs 
Evaluate removal of antibiotic 
resistant genes Raw domestic 
sewage by CWs with different 
design 
Total community DNA  
12 genes including three sulfonamide resistance genes 
(sul1, sul2 and sul3), four tetracycline resistance 
genes (tetG, tetM, tetO and tetX), two macrolide 
resistance genes (ermB and ermC), two 
chloramphenicol resistance genes (cmlA and floR) 
Removal efficiency between 63.9 and 84.0% 
HSSF-CWs and VSSF-CWs showed higher removals of pollutants than the SF-CWs Planting 
in the CWs was beneficial to pollutant removal. Mass removals attributed to biodegradation, 
substrate adsorption, and plant uptake. 
  788 
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6. WWTPs design, operation and upgrading for CEC removal: techno-economical evaluations 789 
6.1 Impact of CEC removal implementation on WWTPs design and operation 790 
As pointed out in the previous sections, the effect of wastewater treatment on the fate of CEC 791 
occurring in wastewater depends on different factors including: (i) wastewater characteristics, (ii) 792 
initial concentration of target CEC, (iii) size of WWTPs, (iv) type of biological process/technology, 793 
(v) operating conditions of biological process/technology and (vi) presence of tertiary and/or 794 
advanced treatment. Wastewater characteristics also depend on the size of the WWTP because large 795 
WWTPs (e.g., > 50,000 – 60,000 PE) often collect hospital and industrial wastewater, while small 796 
WWTPs (SWWTPs, < 3,000 – 5,000 PE), particularly those in remote and/or rural area, are not or 797 
little affected by this kind of wastewaters. Moreover, treatment methods in medium/large WWTPs are 798 
basically different compared to small WWTPs. In medium/large WWTPs, CAS, MBRs or MBBRs 799 
are typical options for secondary (biological) treatment, while for small WWTPs (in particular for 800 
those in the low range of PE (e.g. < 1,000-2,000) some options may be not sustainable in terms of 801 
investment and management costs (e.g., MBRs) and cheaper solutions may be used (e.g., CWs, 802 
rotating biological contactors, Imhoff tanks, etc.).  803 
Achieving CEC removal through optimization of existing WWTPs will vary between different 804 
treatment processes, but in general it will be based on adjustment of the operational process 805 
parameters typically proposed in the literature (Omil et al., 2010; Li et al., 2015; Tiwari et al., 2017) 806 
as well as of those, mentioned in early sections, which affect pollutants removal: 807 
- Increased SRT to enhance biodegradation of typically moderately biodegradable compounds 808 
through microbial community diversification due to increased growth of slow growing 809 
microorganisms such as nitrifying bacteria at longer SRTs (Holbrook et al., 2002; Stephenson and 810 
Oppenheimer 2007; Tiwari et al., 2017). Although SRT of above 15 days are typically 811 
recommended (Li et al., 2015), different CEC may require different SRTs for achieving optimal 812 
removal rate. Nevertheless, operation at very high SRT to promote extra biological transformation 813 
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will lead to higher operating costs due to higher oxygen requirements of biomass (Krzeminski et 814 
al., 2017). 815 
- Increased HRT to improve removal of compounds that are moderately biodegradable (high kbiol) 816 
and have low sorption potential (low Kd) (Eggen and Vogelsang 2015). Enhanced CEC removal in 817 
CAS has been reported at HRT of above 16 hours (Guerra et al., 2014). However, HRT also 818 
increases capital costs while CEC removal improvement at higher HRT is still debated (Taheran 819 
et al., 2016).  820 
- Increased MLSS to enhance biodegradation provided by high biological activity per unit volume 821 
leading to generation of slow-growing bacteria able to degrade certain biologically-recalcitrant 822 
pollutants (Bernhard et al., 2006; Sipma et al., 2010; Clouzot et al., 2011; Tran et al., 2013).  823 
- Implementation of nutrient removal stages associated with varying redox conditions (nitrification 824 
and de-nitrification) leading to increased microbial diversity, broad enzymatic range and 825 
microorganisms’ activity. Heterotrophic microbes are of importance for fast biodegradable 826 
compounds whereas lithotrophic ammonia oxidizers and nitrifyers are of importance for slowly 827 
biodegradable compounds (Tran et al., 2013). In particular, presence of anoxic zones and high 828 
ammonia loading rates seems to favour CEC removal in CAS (Li et al., 2015). 829 
- Presence of fat during primary treatment that favours absorption of lipophilic compounds with 830 
high Kow such as musks (Li et al., 2015). 831 
- Combination of different processes, such as CAS and CWs, or combination of CWs with different 832 
designs, as varying redox conditions should significantly improve pollutants removal. 833 
The possibility of establishing favourable operating conditions for CEC removal is different for 834 
large/medium WWTPs and small WWTPs. For example, in CAS process, large WWTPs are operated 835 
with high organic loading rate (> 0.5 kg BOD5/(kg MLVSS×d)), which typically results in designing 836 
aeration/nitrification tank with relatively low hydraulic retention time (HRT, 6 – 12 h) and sludge 837 
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retention time (SRT, 3 – 6 d). Differently, CAS process in SWWTPs is typically designed to operate 838 
under extended aeration conditions (< 0.05 kg BOD5/(kg MLVSS×d), which results in larger 839 
aeration/nitrification tank (HRT= 36 – 48 h, SRT= 30 – 40 d) (Metcalf and Eddy 2003). 840 
Other factors influencing CEC removal often mentioned in the literature, such as temperature, content 841 
of organic matter, ionic strength and conductivity, were considered less realistic for implementation at 842 
the full-scale, and thus not discussed further.  843 
6.2 Feasibility of WWTPs upgrading to remove CEC  844 
Possible solutions to successfully minimize the release of CEC into the environment from WWTPs 845 
effluents consist of implementation of an effective tertiary treatment, upgrading through re-designing 846 
of the existing treatment processes or optimizing operating conditions of the existing biological 847 
process according to the flow chart reported in Figure 1.  848 
 849 
Figure 1: Flow chart for decision making on upgrading conventional WWTPs for CEC removal 850 
 851 
The likelihood of implementation of dedicated treatment for CEC removal depends not only on the 852 
performance aspects of particular process such as removal efficacy and removal mechanisms, range of 853 
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treated pollutants and reliability of removal efficiency, but also on significant number of other factors. 854 
Among these impact factors, ease of construction and set-up, simplicity of operation and maintenance 855 
requirements, flexibility in adapting to the fluctuations in influent flowrate and characteristics, capital 856 
and operating costs, cost-effectiveness, environmental friendliness in respect to waste production and 857 
disposal needs, overall environmental footprint, associated prospects and constraints, development 858 
stage, level of social acceptance, and finally who is supposed to cover the costs of dedicated CEC 859 
treatment are mentioned (Eggen and Vogelsang 2015; Bui et al., 2016; Tiedeken et al., 2017).  860 
However, proper economic comparison between different treatment alternatives discussed in this 861 
review is very difficult due to scarce information in the literature (Bolzonella et al., 2010; Fatone 862 
2010; Krzeminski et al., 2017) and because each treatment design is unique due to its specific site 863 
conditions and operating settings/conditions. The capital and operating costs depend on number of 864 
parameters such as scale of treatment, feed water characteristics, targeted pollutants, desired water 865 
quality and electricity, chemicals and personnel costs, which vary from country to country (Bui et al., 866 
2016; Taheran et al., 2016).  867 
Furthermore, holistic assessment of different alternatives taking into account environmental impacts 868 
is needed to quantify benefits of CEC removal. Approaches, such as Life Cycle Assessment 869 
(Corominas et al., 2013), nonmarket valuation (Kotchen et al., 2009; Logar et al., 2014) and distance 870 
function approach based on shadow prices, to quantify environmental benefits from reduced 871 
discharges of CEC (Molinos-Senante et al., 2013) have been proposed (Schröder et al., 2016; 872 
Tiedeken et al., 2017). For example, research findings of the LCA studies review (Corominas et al., 873 
2013) indicate that in general environmental benefits do not outweigh the costs of advanced treatment 874 
implementation. However, LCA studies evaluating secondary treatment alternatives for the removal 875 
of CEC to the best authors’ knowledge have not been published.  876 
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Alternatively, in cases when the implementation costs would outweigh the environmental benefits, or 877 
if cost would be considered too great, existing WWTPs could be optimized for CEC removal (Jones et 878 
al., 2007) by adjusting operating parameters reported in the previous section.  879 
6.3 Techno-economical comparison of the selected technologies 880 
To define the technology to be implemented for achieving a more effective removal of the selected 881 
CEC and producing effluents suitable for re-use, a comparison of the proposed technological 882 
solutions, summarizing the data reported in the manuscript, is reported in Table 8. In order to achieve 883 
an integrated, coherent comparative efficiency assessment of the examined technologies, besides the 884 
achievable removal efficiencies, other evaluation parameters such as complexity in lay out and 885 
management, scale of application and need of a post-treatment are included. It is worth noting that 886 
updated specific quantitative cost data related with CEC removal in discussed secondary treatment 887 
processes are not available in scientific literature, thus a qualitative evaluation based on the literature 888 
review has been performed, where some important economic factors (i.e. energy and chemical 889 
consumptions) are being discussed. 890 
In addition, with the objective to give a first simplified comparative evaluation of the technologies, a 891 
score was assigned in a scale from 1 to 4, where 1 is the worst and 4 is the best evaluation of each 892 
technology, according to each examined parameter. The score was determined based on the available 893 
technical data elaborated for the purposes of this review.  894 
The ARB&ARGs removal figures are not reported in Table 8 because data available is scarce and not 895 
following a systematic protocol of analyses, leading to results biased by large variability in the nature 896 
of approaches reported in the existing in scientific literature so far. Majority of studies examines 897 
prevalence of resistance in selected isolated colonies and does not focus on the removal of 898 
ARB&ARGs as such. In addition, many studies report removal efficiencies at the end of the WWTP 899 
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which may involve a tertiary or disinfection step and do not provide data on the actual biological 900 
process removal efficiency.  901 
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Table 8. Techno-economical comparative evaluation of the proposed technologies to produce effluents suitable for reuse. Data for the 902 
different groups of CEC are with reference to the ones included in this review. A score assigned in a scale from 1 to 4 (where 1 is the worst 903 
and 4 is the best evaluation of each technology according to the examined parameter) is reported in parentheses.  904 
Parameter Group of compounds 
Technology 
CAS MBR MBBR CW 
Range of removal 
efficiencies (%) 
Pharmaceuticals  <0 – 90 <0 – 99  0 – 100  0 – 99 
Antibiotics <0 – 90 <0 – 99  <0 – 96 0 – 100  
PCPs 30 – 55 N.A. N.A. N.A. 
Estrogens 18 – 96 20 – 100  65 – 100  0 – 100 
Neonicotinoids 11 – 18 N.A. N.A. N.A. 
Pesticides N.A. N.A. N.A. N.A. 
Industrial chemicals <0 – 100 <0 – 94  43 – 76  8 – 100 
Need of post-treatment  YES  NO YES YES/NO 
Complexity in lay out/Ease of construction   ▪ Simple lay out  
(4) 
▪ Commercially available, 
TRL=9 
(4) 
▪ Commercially 
available and 
simpler than CAS 
(2 -3) 
▪ Ease of construction 
▪ Commercially 
available 
(4) 
Complexity in operation ▪ Easy management not 
requiring complex 
control systems  
(4) 
▪ High process 
automation 
▪ Skilled staff needed 
(2-3) 
▪ Easy management  
▪ Needs maintenance 
▪ (retention grids of 
media) 
▪ Simpler than CAS 
(2-3) 
▪ Easy management 
▪ Needs maintenance 
(3) 
Flexibility  ▪ Low flexibility due to 
high inertia of the system 
in changing operating 
conditions  
(1) 
▪ High, modular system 
(4) 
▪ Good flexibility 
(media addition / 
HYBAS system) 
(3) 
▪ Low flexibility, not 
possible to change 
design 
(2) 
Reliability ▪ Not resilient to 
permanent inflow 
variation  
▪ Not resilient to influent 
shock load  
(1-2) 
▪ Stable effluent 
▪ Resilient to inflow 
fluctuations 
▪ Relatively resilient to 
shocks  
(3-4) 
▪ Stable effluent 
▪ Very resilient to 
flow fluctuation 
▪ Very resilient to 
shock loads 
(3) 
▪ Relatively resilient to 
flow fluctuation 
▪ Relatively resilient to 
shock loads 
▪ Can be dependent on 
temperature 
(seasonality effect) 
(2) 
Footprint ▪ Large footprint  
(1) 
▪ Small footprint 
▪ Space reduction 
possible 
▪ Larger/similar to 
MBRs and less 
than CAS and 
▪ Large areas required 
(2) 
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Parameter Group of compounds 
Technology 
CAS MBR MBBR CW 
(4) CWs 
                   (3) 
 
Environmental aspects (waste production, 
disposal, chemicals) 
▪ Production of sludge 
containing residual CEC  
(2) 
▪ Treatment of 
concentrate and sludge 
containing CEC 
(3) 
▪ Low sludge 
production but 
containing residual 
CEC  
▪ Less sludge than 
CAS. 
▪ Carriers have very 
long lifetime 
(3) 
 
▪ Need previous 
filtration step to 
prevent clogging 
▪ Might need post 
treatment to remove 
some recalcitrant CEC 
(3) 
Investment cost ▪ Lower than MBRs and 
MBBRs 
(4) 
▪ Typically, higher than 
CAS 
▪ Membrane cost ca. 40-
60% of total capital 
costs  
(2) 
▪ Higher than CAS 
and CWs, but less 
than MBRs 
(2-3) 
▪ Reduced costs 
compared to CAS 
(4) 
Management cost ▪ Energy 0.2-1.4 kWh/m3 
(4) 
▪ Energy 0.4-4.2 kWh/m3 
▪ Membrane replacement 
ca. 10-14% of total 
operation costs  
▪ Chemicals for 
membrane cleaning 
 (2) 
▪ Slightly higher 
aeration than CAS 
needed.  
▪ Less than MBRs, 
more than CWs 
and CAS  
(3) 
 
▪ Reduced costs 
compared to CAS 
(4) 
 
Legend: N.A. – not available;  
 905 
 906 
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7. Future perspectives and research needs 907 
Despite significant research and monitoring efforts devoted to presence and fate of CEC, data on 908 
occurrence and/or removal of some of the emerging compounds are not available. Nevertheless, this 909 
review shows the potential of four secondary biological treatment technologies for the removal of 910 
selected CEC and the need to reach effluent quality suitable for reuse of treated water for e.g. 911 
irrigation purposes. This in turn, allows defining the research needs for the analysed technologies in 912 
respect to the removal of CEC. 913 
CAS process is the most investigated process for the removal of CEC. However, the conventional 914 
layout (i.e. aerobic process) is ineffective, while operation at high SRT or with sequential anoxic-915 
aerobic phases can ameliorate their performance for some pharmaceutical compounds. Thus, 916 
research should be devoted to the optimization of the process performance by modifying the 917 
operating parameters (when possible), and/or investigating the combination with more powerful 918 
technologies to be applied as tertiary treatment.     919 
MBR technology has been extensively investigated for the removal of CEC, but the mechanisms 920 
have not yet been fully unravelled. Further research is needed to understand removal mechanisms of 921 
the CEC and microbiological contaminants such as ARB&ARGs. For example, fouling layer 922 
interaction and the role of deposits on the membrane surface as potential additional barrier increasing 923 
CEC removal is needed. In addition, identification of CEC removing bacterial species and/or 924 
enzymes, unravelling optimal operating conditions, and elucidation of the metabolites produced 925 
during MBR treatment is required. These products may possess different structural characteristics 926 
compared to the parent compounds, making them toxic once they are filtered and end up in the 927 
clarified MBR effluent. Finally, cost-effective integrated MBR systems providing synergistic effects 928 
of combined technologies, should be further developed with emphasis on system optimization, 929 
scaling up, and full-scale validation.  930 
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The removal of chemical and microbial CEC by CWs is a recent area of study, and current CWs are 931 
not able to effectively eliminate CEC from wastewater. Therefore, more research is needed to 932 
identify the feasibility for full-scale applications. The efficiency of the processes occurring in CWs 933 
depends primarily on the operation mode, design, type of substrate and the presence and type of 934 
plants. Therefore, studies should be designed to reveal the effect of each process on CEC. Only with 935 
that information one can optimize CWs design and operating parameters, consequently getting better 936 
treatment efficiency and fully supporting CWs utility. In addition, the effectiveness of the processes 937 
in the CWs can be increased by the use of hybrid systems that combine CWs of different designs in 938 
series or by combining CWs with other processes e.g. solar driven homogeneous advanced oxidation 939 
processes (e.g., sunlight mild photo Fenton, sunlight/H2O2). As CWs have some specific 940 
prerequisites, such as large areas requirements and the fact that it can be dependent on temperature 941 
(seasonality effect), their application is site dependant. 942 
The number of wastewater treatment plants designed using the MBBR technology as the main 943 
secondary treatment process around the world is estimated by Veolia to be between 20 and 50, 944 
mainly in Scandinavia, China and the United States. Even less studies investigated the fate of CEC 945 
throughout the process treatment at full-scale. The added value of biofilm for the elimination of CEC 946 
still needs to be investigated in laboratory scale and up-scaled to real applications. The global 947 
understanding of CEC removal pathways (including diffusion into the biofilm, hydrodynamics 948 
conditions) and regulation of bacterial communities on biofilm (through biofilm thickness) should be 949 
in the scope of new research projects. The occurrence of the highly active biomass in the biofilm in 950 
the later stages of MBBR treatment trains could be positive for the removal of recalcitrant organic 951 
CEC, but the generally achieved thin biofilm contains too little biomass to complete the CEC 952 
degradation in a realistic contact time. This experimental evidence suggests that research should aim 953 
to increase the available biomass retained in these parts of the MBBR treatment train while retaining 954 
the efficient biomass. In this paper, MBBR technology was studied as the secondary treatment. 955 
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However, MBBR as a tertiary treatment should also be considered as an interesting advanced 956 
treatment technology for recalcitrant CEC removal. 957 
However, regardless of the applied technology, the removal of CEC depends on the treatment 958 
conditions and the physicochemical properties of the individual compounds. Furthermore, the current 959 
knowledge suggests that the factors that rule the fate of ARB&ARGs are complex and variable 960 
among different WWTP, making each plant a unique microbial ecosystem. Therefore, it is still 961 
difficult to assess the CEC impact onto the wastewater receiving environments, as well as the 962 
potential ways in which CEC removal can be enhanced. This highlights the need for research to 963 
maximize CEC removal by biological processes while successfully removing conventional 964 
parameters (namely, BOD, COD, nitrogen, phosphorus, etc.) to promote a safer reuse of treated 965 
wastewater. 966 
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Schröder, P., Helmreich, B., Škrbić, B., Carballa, M., Papa, M., Pastore, C., Emre, Z., Oehmen, A., Langenhoff, 1633 
A., Molinos, M., Dvarioniene, J., Huber, C., Tsagarakis, K.P., Martinez-Lopez, E., Pagano, S.M., Vogelsang, C. 1634 
and Mascolo, G. (2016) Status of hormones and painkillers in wastewater effluents across several European 1635 
states—considerations for the EU watch list concerning estradiols and diclofenac. Environmental Science and 1636 
Pollution Research 23(13), 12835-12866. 1637 
Segura, P.A., Francois, M., Gagnon, C. and Sauve, S. (2009) Review of the occurrence of anti-infectives in 1638 
contaminated wastewaters and natural and drinking waters. Environmental Health Perspectives 117(5), 675-1639 
684. 1640 
Segura, P.A., MacLeod, S.L., Lemoine, P., Sauve, S. and Gagnon, C. (2011) Quantification of carbamazepine 1641 
and atrazine and screening of suspect organic contaminants in surface and drinking waters. Chemosphere 1642 
84(8), 1085-1094. 1643 
Senta, I., Terzic, S. and Ahel, M. (2013) Occurrence and fate of dissolved and particulate antimicrobials in 1644 
municipal wastewater treatment. Water Research 47(2), 705-714. 1645 
Sharma, V.K., Johnson, N., Cizmas, L., McDonald, T.J. and Kim, H. (2016) A review of the influence of 1646 
treatment strategies on antibiotic resistant bacteria and antibiotic resistance genes. Chemosphere 150, 702-1647 
714. 1648 
Shojaee Nasirabadi, P., Saljoughi, E. and Mousavi, S.M. (2016) Membrane processes used for removal of 1649 
pharmaceuticals, hormones, endocrine disruptors and their metabolites from wastewaters: a review. 1650 
Desalination and Water Treatment 57(51), 24146-24175. 1651 
Sidrach-Cardona, R. and Bécares, E. (2013) Fecal indicator bacteria resistance to antibiotics in experimental 1652 
constructed wetlands. Ecological Engineering 50, 107-111. 1653 
Siegrist, H. and Joss, A. (2012) Review on the fate of organic micropollutants in wastewater treatment and 1654 
water reuse with membranes. Water Science and Technology 66(6), 1369-1376. 1655 
Singer, H., Muller, S., Tixier, C. and Pillonel, L. (2002) Triclosan: occurrence and fate of a widely used biocide 1656 
in the aquatic environment: field measurements in wastewater treatment plants, surface waters, and lake 1657 
sediments. Environmental Science and Technology 36(23), 4998-5004. 1658 
Sipma, J., Osuna, B., Collado, N., Monclús, H., Ferrero, G., Comas, J. and Rodriguez-Roda, I. (2010) 1659 
Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 250(2), 653-1660 
659. 1661 
Snyder, S.A., Adham, S., Redding, A.M., Cannon, F.S., DeCarolis, J., Oppenheimer, J., Wert, E.C. and Yoon, Y. 1662 
(2007) Role of membranes and activated carbon in the removal of endocrine disruptors and 1663 
pharmaceuticals. Desalination 202(1–3), 156-181. 1664 
Stephenson, R. and Oppenheimer, J. (2007) Fate of Pharmaceuticals and Personal Care Products through 1665 
Municipal Wastewater Treatment Processes. 1666 
Strenn, B., Clara, M., Gans, O. and Kreuzinger, N. (2004) Carbamazepine, diclofenac, ibuprofen and 1667 
bezafibrate - investigations on the behaviour of selected pharmaceuticals during wastewater treatment. 1668 
Water Science and Technology 50(5), 269-276. 1669 
Su, H.C., Ying, G.G., He, L.Y., Liu, Y.S., Zhang, R.Q. and Tao, R. (2014) Antibiotic resistance, plasmid-mediated 1670 
quinolone resistance (PMQR) genes and ampC gene in two typical municipal wastewater treatment plants. 1671 
Environ Sci Process Impacts 16(2), 324-332. 1672 
Suarez, S., Lema, J.M. and Omil, F. (2010) Removal of Pharmaceutical and Personal Care Products (PPCPs) 1673 
under nitrifying and denitrifying conditions. Water Research 44(10), 3214-3224. 1674 
85 
 
Sui, Q., Huang, J., Deng, S., Chen, W. and Yu, G. (2011) Seasonal Variation in the Occurrence and Removal of 1675 
Pharmaceuticals and Personal Care Products in Different Biological Wastewater Treatment Processes. 1676 
Environmental Science & Technology 45(8), 3341-3348. 1677 
Sun, Y., Shen, Y.X., Liang, P., Zhou, J., Yang, Y. and Huang, X. (2016) Multiple antibiotic resistance genes 1678 
distribution in ten large-scale membrane bioreactors for municipal wastewater treatment. Bioresource 1679 
Technology 222, 100-106. 1680 
Taheran, M., Brar, S.K., Verma, M., Surampalli, R.Y., Zhang, T.C. and Valero, J.R. (2016) Membrane processes 1681 
for removal of pharmaceutically active compounds (PhACs) from water and wastewaters. Science of the 1682 
Total Environment 547, 60-77. 1683 
Talib, A. and Randhir, T.O. (2017) Managing emerging contaminants in watersheds: Need for comprehensive, 1684 
systems-based strategies. Sustainability of Water Quality and Ecology 9-10, 1-8. 1685 
Tambosi, J.L., de Sena, R.F., Favier, M., Gebhardt, W., José, H.J., Schröder, H.F. and Moreira, R.d.F.P.M. 1686 
(2010a) Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged 1687 
membranes. Desalination 261(1–2), 148-156. 1688 
Tambosi, J.L., Yamanaka, L.Y., José, H.J., Moreira, R.d.F.P.M. and Schröder, H.F. (2010b) Recent research data 1689 
on the removal of pharmaceuticals from sewage treatment plants (STP). Quimica Nova 33, 411-420. 1690 
Tang, K., Ooi, G.T.H., Litty, K., Sundmark, K., Kaarsholm, K.M.S., Sund, C., Kragelund, C., Christensson, M., 1691 
Bester, K. and Andersen, H.R. (2017) Removal of pharmaceuticals in conventionally treated wastewater by a 1692 
polishing moving bed biofilm reactor (MBBR) with intermittent feeding. Bioresource Technology 236, 77-86. 1693 
Tiedeken, E.J., Tahar, A., McHugh, B. and Rowan, N.J. (2017) Monitoring, sources, receptors, and control 1694 
measures for three European Union watch list substances of emerging concern in receiving waters – A 20 1695 
year systematic review. Science of the Total Environment 574, 1140-1163. 1696 
Tiwari, B., Sellamuthu, B., Ouarda, Y., Drogui, P., Tyagi, R.D. and Buelna, G. (2017) Review on fate and 1697 
mechanism of removal of pharmaceutical pollutants from wastewater using biological approach. Bioresource 1698 
Technology 224, 1-12. 1699 
Torresi, E., Escola Casas, M., Polesel, F., Plosz, B.G., Christensson, M. and Bester, K. (2017) Impact of external 1700 
carbon dose on the removal of micropollutants using methanol and ethanol in post-denitrifying Moving Bed 1701 
Biofilm Reactors. Water Research 108, 95-105. 1702 
Tran, N.H., Chen, H., Reinhard, M., Mao, F. and Gin, K.Y.-H. (2016) Occurrence and removal of multiple 1703 
classes of antibiotics and antimicrobial agents in biological wastewater treatment processes. Water Research 1704 
104, 461-472. 1705 
Tran, N.H. and Gin, K.Y.-H. (2017) Occurrence and removal of pharmaceuticals, hormones, personal care 1706 
products, and endocrine disrupters in a full-scale water reclamation plant. Science of the Total Environment 1707 
599–600, 1503-1516. 1708 
Tran, N.H., Reinhard, M. and Gin, K.Y.-H. (2018) Occurrence and fate of emerging contaminants in municipal 1709 
wastewater treatment plants from different geographical regions-a review. Water Research 133, 182-207. 1710 
Tran, N.H., Urase, T., Ngo, H.H., Hu, J. and Ong, S.L. (2013) Insight into metabolic and cometabolic activities 1711 
of autotrophic and heterotrophic microorganisms in the biodegradation of emerging trace organic 1712 
contaminants. Bioresource Technology 146, 721-731. 1713 
Trinh, T., Coleman, H.M., Stuetz, R.M., Drewes, J.E., Le-Clech, P. and Khan, S.J. (2016a) Hazardous events in 1714 
membrane bioreactors – Part 2: Impacts on removal of trace organic chemical contaminants. Journal of 1715 
Membrane Science 497, 504-513. 1716 
Trinh, T., van den Akker, B., Coleman, H.M., Stuetz, R.M., Drewes, J.E., Le-Clech, P. and Khan, S.J. (2016b) 1717 
Seasonal variations in fate and removal of trace organic chemical contaminants while operating a full-scale 1718 
membrane bioreactor. Science of the Total Environment 550, 176-183. 1719 
Trinh, T., van den Akker, B., Coleman, H.M., Stuetz, R.M., Le-Clech, P. and Khan, S.J. (2012a) Removal of 1720 
endocrine disrupting chemicals and microbial indicators by a decentralised membrane bioreactor for water 1721 
reuse. Journal of Water Reuse and Desalination 2(2), 67-73. 1722 
Trinh, T., van den Akker, B., Stuetz, R.M., Coleman, H.M., Le-Clech, P. and Khan, S.J. (2012b) Removal of trace 1723 
organic chemical contaminants by a membrane bioreactor. Water Science and Technology 66(9), 1856-1863. 1724 
86 
 
Tsui, M.M., Leung, H.W., Lam, P.K. and Murphy, M.B. (2014) Seasonal occurrence, removal efficiencies and 1725 
preliminary risk assessment of multiple classes of organic UV filters in wastewater treatment plants. Water 1726 
Research 53, 58-67. 1727 
Verlicchi, P., Al Aukidy, M. and Zambello, E. (2012) Occurrence of pharmaceutical compounds in urban 1728 
wastewater: Removal, mass load and environmental risk after a secondary treatment—A review. Science of 1729 
the Total Environment 429, 123-155. 1730 
Verlicchi, P. and Zambello, E. (2014) How efficient are constructed wetlands in removing pharmaceuticals 1731 
from untreated and treated urban wastewaters? A review. Science of the Total Environment 470–471, 1281-1732 
1306. 1733 
Vidal‐Dorsch, D.E., Bay, S.M., Maruya, K., Snyder, S.A., Trenholm, R.A. and Vanderford, B.J. (2012) 1734 
Contaminants of emerging concern in municipal wastewater effluents and marine receiving water. 1735 
Environmental Toxicology and Chemistry 31(12), 2674-2682. 1736 
Vieno, N. and Sillanpää, M. (2014) Fate of diclofenac in municipal wastewater treatment plant — A review. 1737 
Environment International 69(0), 28-39. 1738 
Vieno, N. and Toivikko, S. (2014) The occurrence of environmentally relevant hazardous substances in 1739 
Finnish wastewater treatment plants. IWA World Water Conference and Exhibition, Lisbon. 1740 
Vieno, N.M., Tuhkanen, T. and Kronberg, L. (2005) Seasonal Variation in the Occurrence of Pharmaceuticals 1741 
in Effluents from a Sewage Treatment Plant and in the Recipient Water. Environmental Science & 1742 
Technology 39(21), 8220-8226. 1743 
Vymazal, J. (2011a) Constructed wetlands for wastewater treatment: five decades of experience. Environ Sci 1744 
Technol. 45(1), 61-69. 1745 
Vymazal, J. (2011b) Water and Nutrient Management in Natural and Constructed Wetlands, Springer. 1746 
Vymazal, J. and Březinová, T. (2015) Heavy metals in plants in constructed and natural wetlands: 1747 
concentration, accumulation and seasonality. Water Science and Technology 71(2), 268-276. 1748 
Vymazal, J., Dvořáková Březinová, T., Koželuh, M. and Kule, L. (2017) Occurrence and removal of 1749 
pharmaceuticals in four full-scale constructed wetlands in the Czech Republic – the first year of monitoring. 1750 
Ecological Engineering 98, 354-364. 1751 
Wang L., L.Y., Shang X.,  Shen J. (2014) Occurrence and removal of N-nitrosodimethylamine and its 1752 
precursors in wastewater treatment plants in and around Shanghai. Frontiers of Environmental Science & 1753 
Engineering 8 (4), 519–530. 1754 
Watkinson, A.J., Murby, E.J. and Costanzo, S.D. (2007) Removal of antibiotics in conventional and advanced 1755 
wastewater treatment: Implications for environmental discharge and wastewater recycling. Water Research 1756 
41(18), 4164-4176. 1757 
Weiss, S. and Reemtsma, T. (2008) Membrane bioreactors for municipal wastewater treatment – A viable 1758 
option to reduce the amount of polar pollutants discharged into surface waters? Water Research 42(14), 1759 
3837-3847. 1760 
Wen, Q., Yang, L., Duan, R. and Chen, Z. (2016) Monitoring and evaluation of antibiotic resistance genes in 1761 
four municipal wastewater treatment plants in Harbin, Northeast China. Environmental Pollution 212, 34-40. 1762 
Wijekoon, K.C., Hai, F.I., Kang, J., Price, W.E., Guo, W., Ngo, H.H. and Nghiem, L.D. (2013) The fate of 1763 
pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides during MBR treatment. 1764 
Bioresource Technology 144(0), 247-254. 1765 
Wu, C., Xue, W., Zhou, H., Huang, X. and Wen, X. (2011a) Removal of endocrine disrupting chemicals in a 1766 
large scale membrane bioreactor plant combined with anaerobic-anoxic-oxic process for municipal 1767 
wastewater reclamation. Water Science and Technology 64(7), 1511-1518. 1768 
Wu, J., Huang, X., Li, H., Wei, C. and Wang, J. (2011b) Seasonal variation of activated sludge mixed liquors in 1769 
a long-term steadily-operating membrane bioreactor. 6th IWA Specialist Conference on Membrane 1770 
Technology for Water & Wastewater Treatment, Aachen, Germany. 1771 
Wu, S., Carvalho, P.N., Muller, J.A., Manoj, V.R. and Dong, R. (2016) Sanitation in constructed wetlands: A 1772 
review on the removal of human pathogens and fecal indicators. Science of the Total Environment 541, 8-22. 1773 
87 
 
Xu, J., Xu, Y., Wang, H., Guo, C., Qiu, H., He, Y., Zhang, Y., Li, X. and Meng, W. (2015) Occurrence of antibiotics 1774 
and antibiotic resistance genes in a sewage treatment plant and its effluent-receiving river. Chemosphere 1775 
119, 1379-1385. 1776 
Xue, W., Wu, C., Xiao, K., Huang, X., Zhou, H., Tsuno, H. and Tanaka, H. (2010) Elimination and fate of 1777 
selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane 1778 
bioreactor for municipal wastewater reclamation. Water Research 44(20), 5999-6010. 1779 
Yang, S. and Carlson, K.H. (2004) Solid-phase extraction-high-performance liquid chromatography-ion trap 1780 
mass spectrometry for analysis of trace concentrations of macrolide antibiotics in natural and waste water 1781 
matrices. Journal of Chromatography A 1038(1-2), 141-155. 1782 
Yang, X., Flowers, R.C., Weinberg, H.S. and Singer, P.C. (2011) Occurrence and removal of pharmaceuticals 1783 
and personal care products (PPCPs) in an advanced wastewater reclamation plant. Water Research 45(16), 1784 
5218-5228. 1785 
Yang, Y., Li, B., Zou, S., Fang, H.H. and Zhang, T. (2014) Fate of antibiotic resistance genes in sewage 1786 
treatment plant revealed by metagenomic approach. Water Research 62, 97-106. 1787 
Yang, Y., Ok, Y.S., Kim, K.-H., Kwon, E.E. and Tsang, Y.F. (2017) Occurrences and removal of pharmaceuticals 1788 
and personal care products (PPCPs) in drinking water and water/sewage treatment plants: A review. Science 1789 
of the Total Environment 596–597, 303-320. 1790 
Ying, G.G. and Kookana, R.S. (2007) Triclosan in wastewaters and biosolids from Australian wastewater 1791 
treatment plants. Environment International 33(2), 199-205. 1792 
Yoon, S., Nakada, N. and Tanaka, H. (2011) Occurrence and removal of NDMA and NDMA formation 1793 
potential in wastewater treatment plants. Journal of Hazardous materials 190(1-3), 897-902. 1794 
Zanotto, C., Bissa, M., Illiano, E., Mezzanotte, V., Marazzi, F., Turolla, A., Antonelli, M., De Giuli Morghen, C. 1795 
and Radaelli, A. (2016) Identification of antibiotic-resistant Escherichia coli isolated from a municipal 1796 
wastewater treatment plant. Chemosphere 164, 627-633. 1797 
Zeng, X., Liu, Z., He, L., Cao, S., Song, H., Yu, Z., Sheng, G. and Fu, J. (2015) The occurrence and removal of 1798 
organophosphate ester flame retardants/plasticizers in a municipal wastewater treatment plant in the Pearl 1799 
River Delta, China. Journal of Environmental Science and Health, Part A 50, 7. 1800 
Zhang, C., Yan, H., Li, F. and Zhou, Q. (2015a) Occurrence and fate of perfluorinated acids in two wastewater 1801 
treatment plants in Shanghai, China. Environ Sci Pollut Res Int 22(3), 1804-1811. 1802 
Zhang, D., Gersberg, R.M., Ng, W.J. and Tan, S.K. (2014) Removal of pharmaceuticals and personal care 1803 
products in aquatic plant-based systems: A review. Environmental Pollution 184, 620-639. 1804 
Zhang, S., Han, B., Gu, J., Wang, C., Wang, P., Ma, Y., Cao, J. and He, Z. (2015b) Fate of antibiotic resistant 1805 
cultivable heterotrophic bacteria and antibiotic resistance genes in wastewater treatment processes. 1806 
Chemosphere 135, 138-145. 1807 
Zhang, W., Zhang, Y.T., Taniyasu, S., Yeung, L.W.Y., Lam, P.K.S., Wang, J.S., Li, X.H., Yamashita, N. and Dai, J.Y. 1808 
(2013) Distribution and fate of perfluoroalkyl substances in municipal wastewater treatment plants in 1809 
economically developed areas of China. Environmental Pollution 176, 10-17. 1810 
Zhou, L.J., Ying, G.G., Liu, S., Zhao, J.L., Yang, B., Chen, Z.F. and Lai, H.J. (2013) Occurrence and fate of eleven 1811 
classes of antibiotics in two typical wastewater treatment plants in South China. Science of the Total 1812 
Environment 452, 365-376. 1813 
Zhou, Y., Zha, J. and Wang, Z. (2012) Occurrence and fate of steroid estrogens in the largest wastewater 1814 
treatment plant in Beijing, China. Environmental Monitoring and Assessment 184(11), 6799-6813. 1815 
Zonja, B., Perez, S. and Barcelo, D. (2016) Human Metabolite Lamotrigine-N(2)-glucuronide Is the Principal 1816 
Source of Lamotrigine-Derived Compounds in Wastewater Treatment Plants and Surface Water. 1817 
Environmental Science and Technology 50(1), 154-164. 1818 
Zuehlke, S., Duennbier, U., Lesjean, B., Gnirss, R. and Buisson, H. (2006) Long-Term Comparison of Trace 1819 
Organics Removal Performances Between Conventional and Membrane Activated Sludge Processes. Water 1820 
Environment Research 78(13), 2480-2486. 1821 
Zupanc, M., Kosjek, T., Petkovsek, M., Dular, M., Kompare, B., Sirok, B., Blazeka, Z. and Heath, E. (2013) 1822 
Removal of pharmaceuticals from wastewater by biological processes, hydrodynamic cavitation and UV 1823 
treatment. Ultrasonics Sonochemistry 20(4), 1104-1112. 1824 
88 
 
 1825 
